{ "TCGA-E7-A97P": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "18E6BDB0-B62D-4367-86E9-BEFBBF5E458C", "AGE": 73, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 13.0, "DAYS_TO_BIRTH": -26956.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/18/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 45.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 14.36696584, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.36696584, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.36696584, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.36696584, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-E7-A97P-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3186, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.433333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 42.0 }, "treatments": [] }, "TCGA-K4-A3WS": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "68ADACD1-A16E-4489-9E68-792A6BD8811C", "AGE": 66, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 761.0, "DAYS_TO_BIRTH": -24124.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/6/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 292.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.0189039, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.0189039, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.0189039, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.0189039, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-K4-A3WS-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "K4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3383, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.866666667, "TISSUE_SOURCE_SITE": "ABS - Lahey Clinic", "TBL_SCORE": 188.0 }, "treatments": [] }, "TCGA-4Z-AA7O": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "835084D6-9F1E-408B-A58C-9D60493BBC6A", "AGE": 64, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 512.0, "DAYS_TO_BIRTH": -23645.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/21/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 71.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.83269224, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.83269224, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.83269224, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.83269224, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-4Z-AA7O-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "4Z", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3371, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.5, "TISSUE_SOURCE_SITE": "Barretos Cancer Hospital", "TBL_SCORE": 44.0 }, "treatments": [] }, "TCGA-GU-A767": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "BFABA069-0914-46B4-927D-B5EA3A4A341F", "AGE": 81, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -29739.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/19/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 78.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 4.734194694, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 4.734194694, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 4.734194694, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GU-A767-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3258, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 12.2, "TISSUE_SOURCE_SITE": "BLN - UT Southwestern Medical Center at Dallas", "TBL_SCORE": 336.0 }, "treatments": [] }, "TCGA-CU-A0YN": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "679a6869-2ce9-4472-8db1-8869e2c1a440", "AGE": 60, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -21927.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 67.4, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 12.92040635, "DSS_STATUS": null, "DSS_MONTHS": 12.92040635, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.92040635, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-CU-A0YN-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "CU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2856, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.866666667, "TISSUE_SOURCE_SITE": "UNC", "TBL_SCORE": 113.0 }, "treatments": [] }, "TCGA-GV-A6ZA": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "F5C187EF-DC08-4466-932A-43AA33285673", "AGE": 54, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 691.0, "DAYS_TO_BIRTH": -19871.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/7/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 88.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.71755926, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.71755926, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.71755926, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.71755926, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GV-A6ZA-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GV", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3131, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.733333333, "TISSUE_SOURCE_SITE": "BLN - Cleveland Clinic", "TBL_SCORE": 78.0 }, "treatments": [] }, "TCGA-XF-AAN0": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "E7E95597-EF88-4442-8C01-8D633822E7B5", "AGE": 68, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -24877.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/19/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 75.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 56.48157281, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 56.48157281, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 19.82444028, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-AAN0-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3361, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 13.06666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 18.0 }, "treatments": [ { "START_DATE": 53, "STOP_DATE": 53.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1265, "STOP_DATE": 1318.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1265, "STOP_DATE": 1318.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1423, "STOP_DATE": 1486.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1465, "STOP_DATE": 1486.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1598, "STOP_DATE": 1598.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1598, "STOP_DATE": 1598.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1703, "STOP_DATE": 1703.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Temozolomide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "mtor inhibitor", "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1703, "STOP_DATE": 1703.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vincristine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "anti-mitotic, vinca alkaloid", "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 53, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 53, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 614, "STOP_DATE": 866.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Halichondrin B", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "anti-tubulin agent", "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 898, "STOP_DATE": 1052.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Ifosfamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 898, "STOP_DATE": 1052.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 898, "STOP_DATE": 1052.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1094, "STOP_DATE": 1136.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1094, "STOP_DATE": 1136.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FD-A43Y": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "D349FAE0-DD40-4292-908C-AC86A9938240", "AGE": 65, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 369.0, "DAYS_TO_BIRTH": -23889.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/28/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 107.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 15.58339087, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.58339087, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.58339087, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.58339087, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A43Y-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3318, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.9, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 158.0 }, "treatments": [] }, "TCGA-DK-A2I6": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "DE810AF0-4C18-4E8F-9836-F8ABC425E3EB", "AGE": 81, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2656.0, "DAYS_TO_BIRTH": -29789.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 88.5, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 87.31959102, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 87.31959102, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 87.31959102, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A2I6-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.312, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.266666667, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 437.0 }, "treatments": [] }, "TCGA-XF-AAMH": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "0EC37C2C-8D90-48C1-9CBC-69FE6473C980", "AGE": 80, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -29547.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/9/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 87.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 11.3094651, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 11.3094651, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.29029819, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-AAMH-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3462, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.9, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 8.0 }, "treatments": [] }, "TCGA-E7-A677": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "D492383F-5449-4845-BFB3-B2CB4EB49C4E", "AGE": 81, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 820.0, "DAYS_TO_BIRTH": -29613.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/27/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 41.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.95860867, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 26.95860867, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 26.95860867, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 26.95860867, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-E7-A677-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3003, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.166666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 16.0 }, "treatments": [] }, "TCGA-ZF-A9RD": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "F57122DD-A6F1-484D-B08A-CB1194DE2F9D", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -27496.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 64.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 13.41355163, "DSS_STATUS": null, "DSS_MONTHS": 13.41355163, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.41355163, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-A9RD-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3238, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.266666667, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 72.0 }, "treatments": [] }, "TCGA-4Z-AA7Y": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "49EA6676-AE27-4CA0-A7B3-48423D606D48", "AGE": 60, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1522.0, "DAYS_TO_BIRTH": -22056.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/8/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 78.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 50.03780781, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.03780781, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 50.03780781, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 50.03780781, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-4Z-AA7Y-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "4Z", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3253, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.8, "TISSUE_SOURCE_SITE": "Barretos Cancer Hospital", "TBL_SCORE": 19.0 }, "treatments": [] }, "TCGA-GV-A3QF": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "47990D5E-A0E1-4752-86F5-4F5B84E219DF", "AGE": 79, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 232.0, "DAYS_TO_BIRTH": -28890.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/18/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 74.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 20.28470921, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.28470921, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.28470921, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GV-A3QF-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GV", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.332, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.233333333, "TISSUE_SOURCE_SITE": "BLN - Cleveland Clinic", "TBL_SCORE": 213.0 }, "treatments": [ { "START_DATE": 197, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 197, "STOP_DATE": 261.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DK-AA6P": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "4E702CA1-C0E0-4B9C-B9C7-7D7946818561", "AGE": 72, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 457.0, "DAYS_TO_BIRTH": -26560.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/7/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 66.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.02449288, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.02449288, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 0.526021633, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-AA6P-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3319, "MSI_SENSOR_SCORE": 0.48, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.733333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 334.0 }, "treatments": [ { "START_DATE": 27, "STOP_DATE": 99.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Not Specified", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 27, "STOP_DATE": 99.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Not Specified", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DK-A6B1": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "0D2CD56C-09C6-467D-B3AA-1F7FE0CC60E1", "AGE": 67, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2049.0, "DAYS_TO_BIRTH": -24607.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/6/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 107.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 67.36364533, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 67.36364533, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 67.36364533, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 67.36364533, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A6B1-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3087, "MSI_SENSOR_SCORE": 0.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.2, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 56.0 }, "treatments": [] }, "TCGA-BT-A2LB": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "D17A5AB1-3789-4652-AFF5-D8F4F2291F9C", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 170.0, "DAYS_TO_BIRTH": -26846.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/26/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.1", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 82.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 16.1751652, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.1751652, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.1751652, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.1751652, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A2LB-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3058, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 34.46666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 81.0 }, "treatments": [] }, "TCGA-KQ-A41O": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "9DD41965-7A62-464D-8A23-5C3F9565DD91", "AGE": 84, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1538.0, "DAYS_TO_BIRTH": -30774.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "7/13/2015", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 50.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 50.56382944, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.56382944, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 50.56382944, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-KQ-A41O-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "KQ", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3385, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.066666667, "TISSUE_SOURCE_SITE": "Cornell Medical College", "TBL_SCORE": 87.0 }, "treatments": [] }, "TCGA-K4-A6FZ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "610811D5-E45E-4A4F-BDC1-8D700EFD6E43", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 55.0, "DAYS_TO_BIRTH": -27686.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/12/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 83.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.808199362, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.808199362, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.808199362, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.808199362, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-K4-A6FZ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "K4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3253, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 23.9, "TISSUE_SOURCE_SITE": "ABS - Lahey Clinic", "TBL_SCORE": 72.0 }, "treatments": [] }, "TCGA-CF-A47T": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "0DB0F02F-94F5-492F-8840-5254792F6879", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 205.0, "DAYS_TO_BIRTH": -21347.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/11/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": 54.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 12.65739554, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 12.65739554, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 4.569812934, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 4.569812934, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A47T-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 11.0 }, "treatments": [ { "START_DATE": 127, "STOP_DATE": 149.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 127, "STOP_DATE": 149.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 127, "STOP_DATE": 139.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "radiographic progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 10.0, "RADIATION_DOSAGE": 30.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-S5-AA26": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "A540FCEC-58A1-4E58-8E0A-8BF73B78E30D", "AGE": 46, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 503.0, "DAYS_TO_BIRTH": -16972.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/17/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 76.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.53680508, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.53680508, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.53680508, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.53680508, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-S5-AA26-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "S5", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3358, "MSI_SENSOR_SCORE": 0.35, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.133333333, "TISSUE_SOURCE_SITE": "University of Oklahoma HSC", "TBL_SCORE": 47.0 }, "treatments": [] }, "TCGA-XF-AAMQ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "82F4C181-E022-4799-9F7F-01ABCDC3803E", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2177.0, "DAYS_TO_BIRTH": -21660.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/13/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 85.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 71.57181839, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 71.57181839, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 71.57181839, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 71.57181839, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-AAMQ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3299, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.633333333, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 115.0 }, "treatments": [] }, "TCGA-XF-A9ST": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "33708951-0A0D-4AD0-B472-23151C9F76F6", "AGE": 68, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -25080.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/28/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 101.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 4.208173061, "DSS_STATUS": null, "DSS_MONTHS": 4.208173061, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 4.208173061, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9ST-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3563, "MSI_SENSOR_SCORE": 0.59, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 17.46666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 224.0 }, "treatments": [] }, "TCGA-ZF-AA4V": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "CCD65BC8-82EF-453E-B4BC-A005CC2262D5", "AGE": 66, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1806.0, "DAYS_TO_BIRTH": -24448.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 85.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 59.37469178, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 59.37469178, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 59.37469178, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 59.37469178, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-AA4V-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3277, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 19.46666667, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 188.0 }, "treatments": [ { "START_DATE": 202, "STOP_DATE": 265.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine + Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-CF-A3MF": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "1E308B12-0590-4DAE-94D0-A539FCF25DF7", "AGE": 34, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 383.0, "DAYS_TO_BIRTH": -12557.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/6/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.59164283, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.59164283, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.59164283, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.59164283, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A3MF-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2754, "MSI_SENSOR_SCORE": 1.87, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.766666667, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 16.0 }, "treatments": [ { "START_DATE": 102, "STOP_DATE": 138.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 50.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-4Z-AA7S": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "F001CC02-8119-4726-B41C-14AC1E6A4216", "AGE": 66, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -24111.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/5/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 34.98043857, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.98043857, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.98043857, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-4Z-AA7S-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "4Z", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3217, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.966666667, "TISSUE_SOURCE_SITE": "Barretos Cancer Hospital", "TBL_SCORE": 95.0 }, "treatments": [] }, "TCGA-CF-A3MG": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "39EFA06A-FFE5-40B3-8F8A-A2D7071BC9E3", "AGE": 48, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 369.0, "DAYS_TO_BIRTH": -17600.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/6/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 62.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.1313739, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.1313739, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.1313739, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.1313739, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A3MG-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3409, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.233333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 42.0 }, "treatments": [] }, "TCGA-ZF-AA4N": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "C692E696-37FE-4FC1-90EB-8E34A91A98FC", "AGE": 74, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -27056.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8010/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 70.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 2.89311898, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 2.89311898, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 2.89311898, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-AA4N-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Bladder Urothelial Carcinoma", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3301, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.033333333, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 47.0 }, "treatments": [] }, "TCGA-ZF-AA5N": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "F78CB4FA-5548-40F8-B71B-663DDE47F539", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -22741.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/7/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 81.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 5.523227143, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 5.523227143, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 5.523227143, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-AA5N-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3314, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-FD-A3B7": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "EF5DD4B3-B77A-444A-B5B0-C999A5A3D129", "AGE": 66, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -24245.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 59.4, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 4.010914949, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 4.010914949, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 3.616398724, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-FD-A3B7-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3411, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.233333333, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 92.0 }, "treatments": [] }, "TCGA-4Z-AA7Q": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "FFAFCBFD-0EB3-4E14-ACD0-4407B641A4A5", "AGE": 79, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -28981.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/5/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 65.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 16.76693954, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.76693954, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.76693954, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-4Z-AA7Q-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "4Z", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3387, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.6, "TISSUE_SOURCE_SITE": "Barretos Cancer Hospital", "TBL_SCORE": 229.0 }, "treatments": [] }, "TCGA-YC-A8S6": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "97D6568C-0A89-4327-8988-71E81EE8DAE6", "AGE": 71, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 293.0, "DAYS_TO_BIRTH": -26130.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/9/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 117.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.632771148, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.632771148, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 9.632771148, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.632771148, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-YC-A8S6-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "YC", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3231, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.266666667, "TISSUE_SOURCE_SITE": "Spectrum Health", "TBL_SCORE": 13.0 }, "treatments": [] }, "TCGA-XF-AAN2": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "987E8157-FBEA-40F3-AA01-0092D6CCEB97", "AGE": 73, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -26720.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/20/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 128.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 61.44590196, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 61.44590196, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 61.44590196, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 61.44590196, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-AAN2-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3328, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 13.8, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 61.0 }, "treatments": [] }, "TCGA-FD-A43U": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "140B83DB-BADD-4B8D-B0F5-0F8C8060A228", "AGE": 70, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 636.0, "DAYS_TO_BIRTH": -25841.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/29/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 91.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.9093599, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.9093599, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 16.33954696, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A43U-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.066666667, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 92.0 }, "treatments": [ { "START_DATE": 97, "STOP_DATE": 187.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 97, "STOP_DATE": 187.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 533, "STOP_DATE": 533.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 10.0, "RADIATION_DOSAGE": 30.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": null, "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-XF-A9SI": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "6B0C8E8D-8ABA-413D-85ED-631653F00CA9", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2423.0, "DAYS_TO_BIRTH": -26719.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/16/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 63.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 79.65940099, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 79.65940099, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 79.65940099, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 79.65940099, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-XF-A9SI-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3327, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.8, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 33.0 }, "treatments": [] }, "TCGA-E7-A5KE": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "514DCD02-0B33-40EF-8EF1-05272045FC39", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 17.0, "DAYS_TO_BIRTH": -28714.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/12/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 41.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.558897985, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.558897985, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.558897985, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-E7-A5KE-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.328, "MSI_SENSOR_SCORE": 0.5, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.7, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 297.0 }, "treatments": [] }, "TCGA-GD-A6C6": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "AADCF26B-C398-489F-A86A-E8DB1B5DB456", "AGE": 64, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 67.0, "DAYS_TO_BIRTH": -23631.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/27/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 57.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.202715587, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.202715587, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.202715587, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.202715587, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GD-A6C6-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3525, "MSI_SENSOR_SCORE": 1.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.733333333, "TISSUE_SOURCE_SITE": "ABS - IUPUI", "TBL_SCORE": 164.0 }, "treatments": [] }, "TCGA-DK-A1AE": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "493a4ff2-37a5-4b79-928d-83dbfe534556", "AGE": 84, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 491.0, "DAYS_TO_BIRTH": -30707.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 62.5, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.14228885, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.14228885, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 6.93691028, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A1AE-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2916, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.633333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 104.0 }, "treatments": [ { "START_DATE": 252, "STOP_DATE": 258.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Palliative", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2700.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-ZF-A9R2": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "AEB08986-A802-43DD-A5B4-17F4EC018790", "AGE": 75, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 642.0, "DAYS_TO_BIRTH": -27537.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 63.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.10661801, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.10661801, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.10661801, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.10661801, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-A9R2-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3339, "MSI_SENSOR_SCORE": 0.23, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.5, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 54.0 }, "treatments": [] }, "TCGA-GC-A3RD": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "6A2155B3-915C-41B1-B730-32E55E0C1FBD", "AGE": 83, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 428.0, "DAYS_TO_BIRTH": -30529.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/24/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 71.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.07107867, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.07107867, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.07107867, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.07107867, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GC-A3RD-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GC", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3513, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.5, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 203.0 }, "treatments": [] }, "TCGA-BT-A2LD": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "9DD97821-7AFD-4982-8B1D-F14F845B79F7", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 111.0, "DAYS_TO_BIRTH": -28673.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/27/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 100.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 20.48196732, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 20.48196732, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 18.24637538, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A2LD-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3572, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.2, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 217.0 }, "treatments": [ { "START_DATE": 458, "STOP_DATE": 611.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 458, "STOP_DATE": 611.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 555, "STOP_DATE": 555.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "radiographic progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-GC-A6I3": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "ACF6BDF3-6349-49DC-B99A-4EDA648EEAC5", "AGE": 90, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 423.0, "DAYS_TO_BIRTH": -32873.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/15/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 132.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.90669691, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.90669691, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.90669691, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-GC-A6I3-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GC", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3265, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.73333333, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 144.0 }, "treatments": [] }, "TCGA-DK-AA6S": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "45EEA556-E97B-4912-8AA9-7E5C709EB52B", "AGE": 60, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 5050.0, "DAYS_TO_BIRTH": -22027.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/7/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 100.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 166.0255778, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 166.0255778, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 17.72035375, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 17.72035375, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-AA6S-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3274, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 17.63333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 167.0 }, "treatments": [ { "START_DATE": 575, "STOP_DATE": 710.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Ifosfamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 575, "STOP_DATE": 710.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 575, "STOP_DATE": 710.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 612, "STOP_DATE": 661.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "radiographic progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 33.0, "RADIATION_DOSAGE": 5940.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-XF-A9SP": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "76388364-EB01-4B16-A2B9-0B6C05B4B386", "AGE": 59, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -21776.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/25/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 86.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 14.92586383, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 14.92586383, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.19166913, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9SP-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3304, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.5, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 133.0 }, "treatments": [] }, "TCGA-E7-A97Q": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "ADA19F65-5256-4C79-B3B9-7B9DA69BE437", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 82.0, "DAYS_TO_BIRTH": -22249.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/18/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 66.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 8.087582602, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 8.087582602, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.087582602, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E7-A97Q-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3288, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.1, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 213.0 }, "treatments": [] }, "TCGA-FD-A6TC": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "00D8E96F-F231-4475-9E9F-C1F8AEC28E4E", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 187.0, "DAYS_TO_BIRTH": -28963.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/5/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 57.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 6.147877832, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 6.147877832, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 6.147877832, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 6.147877832, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-FD-A6TC-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3311, "MSI_SENSOR_SCORE": 0.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 28.9, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 182.0 }, "treatments": [ { "START_DATE": 88, "STOP_DATE": 144.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 88, "STOP_DATE": 144.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-C4-A0EZ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "05935f1d-77c2-46ca-b87a-7a84bce38afd", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -25202.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 76.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 8.975244107, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 8.975244107, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.975244107, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-C4-A0EZ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "C4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2845, "MSI_SENSOR_SCORE": 0.34, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.766666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 179.0 }, "treatments": [ { "START_DATE": 123, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 123, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Etoposide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 243, "STOP_DATE": 243.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-UY-A78K": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "5F587F1B-F835-4869-9E6D-8CB3B9E0610B", "AGE": 60, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -22020.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 65.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 17.62172469, "DSS_STATUS": null, "DSS_MONTHS": 17.62172469, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.62172469, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-UY-A78K-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "UY", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3262, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 25.76666667, "TISSUE_SOURCE_SITE": "University of California San Francisco", "TBL_SCORE": 223.0 }, "treatments": [] }, "TCGA-E7-A7PW": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "045FE498-6A07-41FF-9956-DC0FB0483E7F", "AGE": 63, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 416.0, "DAYS_TO_BIRTH": -23057.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/3/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 55.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.67656245, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.67656245, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 5.720485255, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 5.720485255, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-E7-A7PW-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3332, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.566666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 243.0 }, "treatments": [ { "START_DATE": 174, "STOP_DATE": 235.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 60.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-XF-A9SW": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "F5E03536-26E1-480D-A7BB-010EB8210CD6", "AGE": 85, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -31049.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/5/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 65.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 11.90123944, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 11.90123944, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.90123944, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9SW-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3442, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 65.0 }, "treatments": [] }, "TCGA-XF-A9SY": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "8A83F744-8469-41EF-A4CD-E983F849383F", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 640.0, "DAYS_TO_BIRTH": -22212.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/5/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 64.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.04086531, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.04086531, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 5.523227143, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9SY-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3446, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 13.46666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 63.0 }, "treatments": [ { "START_DATE": 199, "STOP_DATE": 256.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 199, "STOP_DATE": 256.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-C4-A0F0": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "40398c03-a9cc-476b-9ee9-aecf161be43f", "AGE": 60, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 59.0, "DAYS_TO_BIRTH": -22068.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": 80.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.93970477, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.93970477, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.93970477, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-C4-A0F0-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "C4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 26.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2914, "MSI_SENSOR_SCORE": 0.23, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.0, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 49.0 }, "treatments": [] }, "TCGA-KQ-A41Q": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "A21BDD7E-F3CF-4826-9967-7EAFFC0D035A", "AGE": 89, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1429.0, "DAYS_TO_BIRTH": -32511.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/13/2015", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 46.98030707, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 46.98030707, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 43.19952658, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-KQ-A41Q-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "KQ", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.32, "MSI_SENSOR_SCORE": 0.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.733333333, "TISSUE_SOURCE_SITE": "Cornell Medical College", "TBL_SCORE": 218.0 }, "treatments": [] }, "TCGA-DK-AA6L": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "CBE6C328-F7E1-44B2-B4E5-B495F46A7FB7", "AGE": 48, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -17635.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/30/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.1", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 115.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 38.23519742, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 38.23519742, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 30.24624388, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-AA6L-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3309, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 12.76666667, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 236.0 }, "treatments": [] }, "TCGA-GV-A3JV": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "01EE41EF-1894-4408-9E96-A22A1F068190", "AGE": 66, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 134.0, "DAYS_TO_BIRTH": -24243.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/6/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 76.7, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 14.26833679, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 14.26833679, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 4.405431173, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GV-A3JV-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GV", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3362, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.7, "TISSUE_SOURCE_SITE": "BLN - Cleveland Clinic", "TBL_SCORE": 115.0 }, "treatments": [] }, "TCGA-DK-A3IN": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "FC0032DB-B6D8-4DA3-BD1B-BEEC4196ABF0", "AGE": 72, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -26562.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 107.5, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 8.21908801, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 8.21908801, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 8.21908801, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 8.21908801, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A3IN-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3319, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.8, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 82.0 }, "treatments": [] }, "TCGA-DK-A3IL": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "178B28CD-99C3-48DC-8D09-1EF71B4CEE80", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 121.0, "DAYS_TO_BIRTH": -29047.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/10/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 73.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 13.57793339, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.57793339, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.57793339, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A3IL-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3623, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.8, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 57.0 }, "treatments": [] }, "TCGA-XF-A9SM": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "B027F4E2-F260-4D60-A1F4-444BC49C4A0B", "AGE": 76, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1048.0, "DAYS_TO_BIRTH": -27826.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/25/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 110.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.45441694, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.45441694, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.45441694, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.45441694, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9SM-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3449, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.3, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 86.0 }, "treatments": [] }, "TCGA-ZF-A9RE": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "284E175C-3229-4FEE-A627-A49EAC538E3A", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -28622.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 62.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 3.484893316, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 3.484893316, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 3.484893316, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-A9RE-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3249, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.1, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 56.0 }, "treatments": [] }, "TCGA-H4-A2HQ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "CEDE5274-279D-4021-8ACA-5ECC4BF94D66", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 590.0, "DAYS_TO_BIRTH": -23538.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "NX", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 63.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.3970477, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.3970477, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.45467995, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-H4-A2HQ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "H4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 26.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3244, "MSI_SENSOR_SCORE": 0.68, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.23333333, "TISSUE_SOURCE_SITE": "Medical College of Georgia", "TBL_SCORE": 169.0 }, "treatments": [] }, "TCGA-DK-A2HX": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "C728FAC9-5452-4759-A4ED-A366E0F757CB", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 55.0, "DAYS_TO_BIRTH": -29332.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 52.5, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 46.6844199, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 46.6844199, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 46.6844199, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A2HX-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3002, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.2, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 138.0 }, "treatments": [] }, "TCGA-K4-AAQO": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "383BF27A-9216-492E-B4BD-2B4EEF8278DE", "AGE": 56, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 359.0, "DAYS_TO_BIRTH": -20683.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/16/2014", "HISTORY_NEOADJUVANT_TRTYN": "Yes", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 100.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.80261038, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.80261038, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.80261038, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-K4-AAQO-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "K4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3306, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.733333333, "TISSUE_SOURCE_SITE": "ABS - Lahey Clinic", "TBL_SCORE": 119.0 }, "treatments": [ { "START_DATE": 120, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Not Specified", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 120, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Not Specified", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FD-A3B3": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "4B5D873B-BFDA-482E-92A0-BF84C0F9032A", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 392.0, "DAYS_TO_BIRTH": -27068.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 104.33, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 32.02156689, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.02156689, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.02156689, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.02156689, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A3B3-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.298, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.466666667, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 73.0 }, "treatments": [] }, "TCGA-UY-A8OB": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "FE33E5E0-A54D-481A-897C-E32B4708DA69", "AGE": 63, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2109.0, "DAYS_TO_BIRTH": -23360.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/1/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 55.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 69.33622645, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 69.33622645, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 69.33622645, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-UY-A8OB-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "UY", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3436, "MSI_SENSOR_SCORE": 0.27, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.46666667, "TISSUE_SOURCE_SITE": "University of California San Francisco", "TBL_SCORE": 210.0 }, "treatments": [] }, "TCGA-ZF-AA53": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "92C6856A-B26F-4512-BBB1-8A8AFF4636AB", "AGE": 60, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1761.0, "DAYS_TO_BIRTH": -22035.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/14/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 111.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 57.89525594, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 57.89525594, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 57.89525594, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 57.89525594, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-AA53-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3233, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.533333333, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 116.0 }, "treatments": [ { "START_DATE": 68, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 68, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-E5-A2PC": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "4107AE6F-502C-4BDC-BF14-E4B3711CBA38", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1326.0, "DAYS_TO_BIRTH": -22308.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 65.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 43.59404281, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 43.59404281, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 43.59404281, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E5-A2PC-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E5", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3096, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.833333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 81.0 }, "treatments": [] }, "TCGA-HQ-A2OF": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "691ADAA9-196A-4B62-9437-640C4AE6E2B2", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1947.0, "DAYS_TO_BIRTH": -19016.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/25/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.1", "ICD_O_3_HISTOLOGY": "8260/3", "ICD_O_3_SITE": "C67.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 69.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 64.01025742, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 64.01025742, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 29.8188513, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 29.8188513, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-HQ-A2OF-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "HQ", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3243, "MSI_SENSOR_SCORE": 0.3, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.233333333, "TISSUE_SOURCE_SITE": "Ontario Institute for Cancer Research (OICR)", "TBL_SCORE": 101.0 }, "treatments": [] }, "TCGA-BL-A13J": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "556fcbc8-172a-4af1-8822-ae036e8d68e8", "AGE": 65, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -23927.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 2.662984515, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 2.662984515, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 2.662984515, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BL-A13J-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BL", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4, "MSI_SENSOR_SCORE": 0.64, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.466666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 174.7 }, "treatments": [] }, "TCGA-E7-A7XN": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "286CF147-B7F7-4A05-8E41-7FBD3717AD71", "AGE": 66, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 428.0, "DAYS_TO_BIRTH": -24466.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/5/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 48.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.07107867, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.07107867, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 6.246506888, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-E7-A7XN-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3247, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 28.86666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 9.0 }, "treatments": [] }, "TCGA-E7-A541": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "D51ABC3A-A652-4B13-9A41-CE52BE87218B", "AGE": 66, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 529.0, "DAYS_TO_BIRTH": -24206.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/4/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 25.57780189, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.57780189, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.57780189, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.57780189, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E7-A541-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 26.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3155, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.13333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 258.0 }, "treatments": [] }, "TCGA-FD-A5BS": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "B581E799-93D1-4F1C-BCB7-7E7AE86A869E", "AGE": 68, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1639.0, "DAYS_TO_BIRTH": -24963.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/1/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 53.88434099, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 53.88434099, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 53.88434099, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 53.88434099, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A5BS-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3319, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.766666667, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 33.0 }, "treatments": [ { "START_DATE": 777, "STOP_DATE": 854.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 777, "STOP_DATE": 854.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BT-A20U": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "83b41d35-69b1-4218-be1a-8821d8a6899c", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -25761.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 14.95874018, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.95874018, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.95874018, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.95874018, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A20U-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3009, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.833333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 10.0 }, "treatments": [] }, "TCGA-FD-A3N6": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "8C1DD7F7-B74A-4FA2-B6A7-86F0348D2567", "AGE": 43, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 851.0, "DAYS_TO_BIRTH": -15758.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/21/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 142.88, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.97777559, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.97777559, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 27.97777559, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.97777559, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-FD-A3N6-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.229, "MSI_SENSOR_SCORE": 7.81, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.7, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 60.0 }, "treatments": [] }, "TCGA-GC-A3WC": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "DB52C68A-ED44-4EC4-9381-D75F9BCBC29A", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 540.0, "DAYS_TO_BIRTH": -29295.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/25/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 62.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.7532301, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.7532301, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.7532301, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.7532301, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GC-A3WC-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GC", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3029, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.166666667, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 22.0 }, "treatments": [] }, "TCGA-G2-AA3D": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "E1540865-69C2-4B60-A78E-97D0CE2957DC", "AGE": 60, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2139.0, "DAYS_TO_BIRTH": -22205.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/11/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 107.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 70.32251701, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 70.32251701, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 70.32251701, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-G2-AA3D-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "G2", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3279, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.033333333, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 280.0 }, "treatments": [ { "START_DATE": 15, "STOP_DATE": 35.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Erlotinib", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 135, "STOP_DATE": 178.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 135, "STOP_DATE": 178.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 135, "STOP_DATE": 178.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vinblastine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 135, "STOP_DATE": 178.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-2F-A9KR": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "F6D916B0-8E4C-49CB-A0D4-883908F3284F", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 3148.0, "DAYS_TO_BIRTH": -21848.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/19/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 80.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 104.6454285, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 104.6454285, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 101.4564224, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 101.4564224, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-2F-A9KR-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "2F", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3282, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.0, "TISSUE_SOURCE_SITE": "Erasmus MC", "TBL_SCORE": 101.0 }, "treatments": [] }, "TCGA-DK-AA77": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "EB4F8C76-08D9-4BA4-846E-969FDED63A87", "AGE": 61, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 618.0, "DAYS_TO_BIRTH": -22365.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/8/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 81.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.31758556, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.31758556, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 15.3532564, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-DK-AA77-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3357, "MSI_SENSOR_SCORE": 0.13, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.73333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 55.0 }, "treatments": [ { "START_DATE": 601, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Ipilimumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 601, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Nivolumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-K4-A5RI": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "32EFE5E2-E037-4547-8EAD-619F61647639", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 239.0, "DAYS_TO_BIRTH": -24614.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/20/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 11.70398133, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 11.70398133, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.758819081, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-K4-A5RI-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "K4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3098, "MSI_SENSOR_SCORE": 0.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.2, "TISSUE_SOURCE_SITE": "ABS - Lahey Clinic", "TBL_SCORE": 51.0 }, "treatments": [] }, "TCGA-HQ-A5ND": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "001944E5-AF34-4061-9C09-BB9EA346F6FD", "AGE": 78, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -28555.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/30/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 9.008120459, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 9.008120459, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 2.761613571, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-HQ-A5ND-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "HQ", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3046, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.633333333, "TISSUE_SOURCE_SITE": "Ontario Institute for Cancer Research (OICR)", "TBL_SCORE": 108.0 }, "treatments": [ { "START_DATE": 149, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 5.0, "RADIATION_DOSAGE": 20.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-CF-A9FM": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "AAD167AB-4772-4616-AFB3-265E00D4A3F0", "AGE": 50, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 398.0, "DAYS_TO_BIRTH": -18445.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/30/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 53.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.08478811, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.08478811, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.08478811, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.08478811, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A9FM-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Bladder Urothelial Carcinoma", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3169, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 11.0 }, "treatments": [] }, "TCGA-FD-A3SQ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "3071CB51-DCF5-41F7-B047-AFC2DCBF0AAF", "AGE": 62, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -22687.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/16/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 89.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 46.78304895, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 46.78304895, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 32.58046487, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A3SQ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3375, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.266666667, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 56.0 }, "treatments": [ { "START_DATE": 78, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 78, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FD-A3B5": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "462D5A6B-9F39-4AAE-A35B-D06A7811D053", "AGE": 86, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -31442.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 72.57, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 8.942367755, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 8.942367755, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.942367755, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-FD-A3B5-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3672, "MSI_SENSOR_SCORE": 0.38, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.7, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 117.0 }, "treatments": [] }, "TCGA-FD-A5C0": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "0628E443-3D7F-4A38-9D2A-EBC7F4F7E11D", "AGE": 61, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 407.0, "DAYS_TO_BIRTH": -22500.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/2/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 18.08199362, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 18.08199362, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 0.887661505, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A5C0-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3211, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.733333333, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 59.0 }, "treatments": [ { "START_DATE": 160, "STOP_DATE": 307.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 160, "STOP_DATE": 279.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FD-A6TH": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "08D13748-0946-49A1-8EB3-5AFD1DEEBC84", "AGE": 63, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 67.0, "DAYS_TO_BIRTH": -23236.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/5/2013", "HISTORY_NEOADJUVANT_TRTYN": "Yes", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 80.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 4.306802117, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 4.306802117, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 4.142420357, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A6TH-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3428, "MSI_SENSOR_SCORE": 0.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.9, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 98.0 }, "treatments": [] }, "TCGA-BT-A3PJ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "CB664EEF-BE6F-44EF-AA90-6F6DA0E6440A", "AGE": 76, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 789.0, "DAYS_TO_BIRTH": -27821.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/5/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.93944176, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.93944176, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.93944176, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.93944176, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A3PJ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3298, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.8, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 145.0 }, "treatments": [ { "START_DATE": 68, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 68, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DK-A3WY": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "9BB5D187-033E-4E86-A76E-E1A6D20488F7", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 4967.0, "DAYS_TO_BIRTH": -24536.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/31/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.1", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 67.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 163.2968406, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 163.2968406, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 163.2968406, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 163.2968406, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A3WY-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3199, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 132, "STOP_DATE": 235.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 132, "STOP_DATE": 235.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-CF-A1HR": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "39ea19e1-4959-4f1b-9934-54bdaf766842", "AGE": 62, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 389.0, "DAYS_TO_BIRTH": -22777.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/17/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 61.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.78890094, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.78890094, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 9.6656475, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 9.6656475, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A1HR-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2777, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.6, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 106.0 }, "treatments": [] }, "TCGA-XF-AAMG": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "390A29FE-2CFD-43C4-A247-69E692763E17", "AGE": 49, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3364.0, "DAYS_TO_BIRTH": -18021.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 72.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 110.5960483, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 110.5960483, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 110.5960483, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 110.5960483, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-XF-AAMG-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3446, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 30.03333333, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 450.0 }, "treatments": [ { "START_DATE": 74, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 74, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-GC-A3YS": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "4D323B18-CE5A-4516-862D-7ED1FDF1F008", "AGE": 61, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 758.0, "DAYS_TO_BIRTH": -22515.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/4/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 81.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.92027485, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.92027485, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.92027485, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GC-A3YS-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GC", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3571, "MSI_SENSOR_SCORE": 0.23, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.3, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 221.0 }, "treatments": [ { "START_DATE": 73, "STOP_DATE": 146.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 73, "STOP_DATE": 106.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 106, "STOP_DATE": 146.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-GV-A3JX": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "D9DCBB57-F6C2-4465-8A60-AFE876E113CA", "AGE": 59, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 581.0, "DAYS_TO_BIRTH": -21888.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/30/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 63.3, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.10116054, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.10116054, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.10116054, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.10116054, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GV-A3JX-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GV", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3614, "MSI_SENSOR_SCORE": 0.39, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.266666667, "TISSUE_SOURCE_SITE": "BLN - Cleveland Clinic", "TBL_SCORE": 53.0 }, "treatments": [] }, "TCGA-CU-A0YR": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "811b3950-36e7-485f-bc48-aca1eee2ddef", "AGE": 83, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 219.0, "DAYS_TO_BIRTH": -30674.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 75.4, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 15.12312194, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 15.12312194, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.199921097, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-CU-A0YR-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "CU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2754, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.266666667, "TISSUE_SOURCE_SITE": "UNC", "TBL_SCORE": 167.0 }, "treatments": [] }, "TCGA-FD-A6TB": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "389D1E21-5B97-4231-A3D7-71FECB918BEB", "AGE": 82, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 572.0, "DAYS_TO_BIRTH": -30185.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/5/2013", "HISTORY_NEOADJUVANT_TRTYN": "Yes", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 62.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.80527337, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.80527337, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.80527337, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.80527337, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A6TB-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3075, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.133333333, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 50.0 }, "treatments": [] }, "TCGA-DK-AA6U": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "104C8E20-1B29-4D77-9633-359A35BE48FB", "AGE": 64, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 578.0, "DAYS_TO_BIRTH": -23611.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/7/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 94.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.00253148, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.00253148, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.00253148, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.00253148, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-AA6U-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": null, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3194, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 13.96666667, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 304.0 }, "treatments": [ { "START_DATE": 13, "STOP_DATE": 90.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 13, "STOP_DATE": 90.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-GV-A3QG": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "79F23A0E-5AAE-4618-8191-7DD7C0552408", "AGE": 65, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -23847.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/18/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 73.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": null, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": null, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 2.761613571, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GV-A3QG-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GV", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3365, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.033333333, "TISSUE_SOURCE_SITE": "BLN - Cleveland Clinic", "TBL_SCORE": 29.0 }, "treatments": [] }, "TCGA-GD-A3OP": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "31DA07BB-6752-49A3-A7EA-5427C04A9458", "AGE": 84, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 64.0, "DAYS_TO_BIRTH": -30956.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.104086531, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.104086531, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.104086531, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GD-A3OP-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3359, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 22.13333333, "TISSUE_SOURCE_SITE": "ABS - IUPUI", "TBL_SCORE": 23.0 }, "treatments": [] }, "TCGA-GU-A42Q": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "9C46846E-7F66-4936-AF97-50A7B8189D84", "AGE": 67, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 231.0, "DAYS_TO_BIRTH": -24534.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/30/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 89.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 11.3094651, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.3094651, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.3094651, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.3094651, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GU-A42Q-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3256, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.566666667, "TISSUE_SOURCE_SITE": "BLN - UT Southwestern Medical Center at Dallas", "TBL_SCORE": 155.0 }, "treatments": [] }, "TCGA-BT-A20P": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "f48937ed-e294-41f0-8872-7010391167a9", "AGE": 81, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -29634.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 17.88473551, "DSS_STATUS": null, "DSS_MONTHS": 17.88473551, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.88473551, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A20P-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2963, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.9, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 106.0 }, "treatments": [] }, "TCGA-E7-A6MD": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "92D27FEC-30C2-4496-965D-DF509D869EAA", "AGE": 66, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 129.0, "DAYS_TO_BIRTH": -24180.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/25/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 4.241049413, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 4.241049413, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 4.241049413, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E7-A6MD-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3281, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 13.53333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 114.0 }, "treatments": [] }, "TCGA-4Z-AA7R": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "72FE54B5-C1C8-468A-954A-09992429512A", "AGE": 73, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 493.0, "DAYS_TO_BIRTH": -26781.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/1/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 69.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 17.16145577, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 17.16145577, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.60535227, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-4Z-AA7R-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "4Z", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.35, "MSI_SENSOR_SCORE": 0.38, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.73333333, "TISSUE_SOURCE_SITE": "Barretos Cancer Hospital", "TBL_SCORE": 330.0 }, "treatments": [] }, "TCGA-DK-A6B2": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "10C825D7-4E21-43E7-AC95-DDA75FBDAF74", "AGE": 70, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 477.0, "DAYS_TO_BIRTH": -25625.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/6/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 107.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.68201992, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.68201992, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.810862347, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A6B2-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3143, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.733333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 249.0 }, "treatments": [ { "START_DATE": 283, "STOP_DATE": 370.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-4Z-AA86": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "939B73D8-39FD-410E-AEAE-53080EA99618", "AGE": 66, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 270.0, "DAYS_TO_BIRTH": -24465.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/21/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.1", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 10.22454548, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 10.22454548, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 4.471183877, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-4Z-AA86-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "4Z", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3293, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.566666667, "TISSUE_SOURCE_SITE": "Barretos Cancer Hospital", "TBL_SCORE": 116.0 }, "treatments": [] }, "TCGA-ZF-AA52": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "6C5F09F0-2019-4440-8554-E8912BCE5E98", "AGE": 70, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -25579.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/14/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 77.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 35.40783115, "DSS_STATUS": null, "DSS_MONTHS": 35.40783115, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 35.40783115, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-AA52-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3286, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.533333333, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 17.0 }, "treatments": [] }, "TCGA-E7-A6MF": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "FAF3C230-C661-4D6E-9B73-2B679BC6DEFF", "AGE": 37, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 750.0, "DAYS_TO_BIRTH": -13867.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/30/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 64.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.65726403, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.65726403, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.65726403, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.65726403, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-E7-A6MF-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3302, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-XF-A8HI": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "EED3908F-F1BD-4254-BCA8-BC1A7427E95C", "AGE": 57, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -21059.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/13/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 92.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 17.88473551, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 17.88473551, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 15.38613276, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A8HI-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3107, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.2, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 13.0 }, "treatments": [ { "START_DATE": 161, "STOP_DATE": 544.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": null, "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FD-A3SL": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "4570B6E2-D430-41CA-AAB1-CE4D14C36463", "AGE": 60, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 683.0, "DAYS_TO_BIRTH": -22020.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/11/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 116.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 23.40796265, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 23.40796265, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.54785153, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A3SL-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3359, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.866666667, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 120.0 }, "treatments": [ { "START_DATE": 302, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 302, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-PQ-A6FN": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "A3C849F2-C006-4368-950D-998A26CD368B", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 507.0, "DAYS_TO_BIRTH": -28546.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/10/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 70.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.66831048, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.66831048, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.66831048, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-PQ-A6FN-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "PQ", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3259, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.533333333, "TISSUE_SOURCE_SITE": "University of Colorado Denver", "TBL_SCORE": 60.0 }, "treatments": [] }, "TCGA-E7-A7DV": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "3EFFD691-570C-478A-8903-3771A1B43F2E", "AGE": 44, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 37.0, "DAYS_TO_BIRTH": -16145.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/5/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 67.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.216425026, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.216425026, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.216425026, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E7-A7DV-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3199, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 16.5, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 366.0 }, "treatments": [] }, "TCGA-FD-A6TK": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "65295450-36CD-45A7-A4A6-2D52EE11378F", "AGE": 60, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 330.0, "DAYS_TO_BIRTH": -21942.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/5/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 54.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.84919617, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.84919617, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.84919617, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.84919617, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A6TK-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3159, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.766666667, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 74.0 }, "treatments": [] }, "TCGA-BT-A20N": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "ebedab7c-dd7c-448e-8324-78c86f13be8b", "AGE": 72, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -26456.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 26.13669987, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 26.13669987, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 26.13669987, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A20N-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2995, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.966666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 216.0 }, "treatments": [ { "START_DATE": 198, "STOP_DATE": 323.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 198, "STOP_DATE": 323.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-XF-A8HF": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "8573E114-AC20-4113-A942-01F2D1562A7B", "AGE": 80, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1709.0, "DAYS_TO_BIRTH": -29288.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/13/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 83.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 97.11674393, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 97.11674393, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 97.11674393, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 97.11674393, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A8HF-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3266, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.866666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 106.0 }, "treatments": [] }, "TCGA-4Z-AA81": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "35C7BB8A-7B5C-488D-9D3A-725B24D14478", "AGE": 80, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 710.0, "DAYS_TO_BIRTH": -29457.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/21/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 78.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 41.75296709, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 41.75296709, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 41.75296709, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 41.75296709, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-4Z-AA81-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "4Z", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3349, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.5, "TISSUE_SOURCE_SITE": "Barretos Cancer Hospital", "TBL_SCORE": 80.0 }, "treatments": [] }, "TCGA-DK-AA74": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "0198D8E5-A14B-44EE-B1C4-D248994845AD", "AGE": 75, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1708.0, "DAYS_TO_BIRTH": -27730.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/7/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.1", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 95.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 56.15280928, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 56.15280928, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 56.15280928, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 56.15280928, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-AA74-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3308, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.333333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 86.0 }, "treatments": [] }, "TCGA-GU-A42R": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "0691B8C5-6244-407C-8601-FA1BDA01FF2A", "AGE": 68, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 344.0, "DAYS_TO_BIRTH": -25134.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/30/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 102.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 18.96965513, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 18.96965513, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 2.991748036, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GU-A42R-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3418, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.333333333, "TISSUE_SOURCE_SITE": "BLN - UT Southwestern Medical Center at Dallas", "TBL_SCORE": 85.0 }, "treatments": [ { "START_DATE": 105, "STOP_DATE": 344.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 105, "STOP_DATE": 344.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 556, "STOP_DATE": 569.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "radiographic progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 10.0, "RADIATION_DOSAGE": 3000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DK-A1A7": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "3ed614e7-f356-4d87-985b-d3bbbae3bb40", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 560.0, "DAYS_TO_BIRTH": -24499.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 48.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.41075714, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.41075714, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 3.682151429, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A1A7-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3021, "MSI_SENSOR_SCORE": 0.96, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.266666667, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 503.0 }, "treatments": [ { "START_DATE": 133, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": 1000.0, "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1st line", "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1300.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 133, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-ZF-A9R1": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "F1BD8305-5C3F-4C82-9E68-BA9CF4ECDF7B", "AGE": 81, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 773.0, "DAYS_TO_BIRTH": -29610.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 83.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.41342013, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.41342013, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 24.92027485, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-A9R1-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3169, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.9, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 102.0 }, "treatments": [] }, "TCGA-FD-A3SM": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "474582F2-8DEC-4FBC-803F-4FD9BA2E0957", "AGE": 70, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 186.0, "DAYS_TO_BIRTH": -25852.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/16/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 98.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 17.98336457, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 17.98336457, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 4.734194694, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A3SM-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3142, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.133333333, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 20.0 }, "treatments": [] }, "TCGA-BT-A3PH": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "932BCDD4-5145-49E8-9A95-8A546396F572", "AGE": 76, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -28030.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/5/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 4.66844199, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 4.66844199, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 4.66844199, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A3PH-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3362, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 13.96666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 58.0 }, "treatments": [] }, "TCGA-HQ-A2OE": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "353C5FCC-9C6A-4AC6-99DC-FB4573B2AE6C", "AGE": 69, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1174.0, "DAYS_TO_BIRTH": null, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/2/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.5968373, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.5968373, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 38.5968373, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-HQ-A2OE-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": null, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "HQ", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3239, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.666666667, "TISSUE_SOURCE_SITE": "Ontario Institute for Cancer Research (OICR)", "TBL_SCORE": 356.0 }, "treatments": [ { "START_DATE": 56, "STOP_DATE": 131.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 56, "STOP_DATE": 131.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-2F-A9KQ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "25EAF3F9-C364-423C-AAAE-925E7B393AFC", "AGE": 69, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2886.0, "DAYS_TO_BIRTH": -25259.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/19/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 72.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 94.88115199, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 94.88115199, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 94.88115199, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 94.88115199, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-2F-A9KQ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "2F", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3181, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.066666667, "TISSUE_SOURCE_SITE": "Erasmus MC", "TBL_SCORE": 27.0 }, "treatments": [] }, "TCGA-FD-A62S": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "05A1402E-5A79-4D54-9430-065844ED1505", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 368.0, "DAYS_TO_BIRTH": -22000.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/23/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 74.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 13.34779893, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 13.34779893, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.06016372, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-FD-A62S-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3156, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.366666667, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 96.0 }, "treatments": [ { "START_DATE": 243, "STOP_DATE": 292.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 243, "STOP_DATE": 292.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-KQ-A41N": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "67CADFFC-460B-4A2A-B182-3794421992B4", "AGE": 73, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1604.0, "DAYS_TO_BIRTH": -26837.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/13/2015", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.6", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.6", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 84.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 52.73366867, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 52.73366867, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 52.73366867, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 52.73366867, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-KQ-A41N-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "KQ", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2975, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 84.6, "TISSUE_SOURCE_SITE": "Cornell Medical College", "TBL_SCORE": 125.0 }, "treatments": [] }, "TCGA-SY-A9G5": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "7D198EE2-D80A-4759-804F-A7EF85971843", "AGE": 66, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1186.0, "DAYS_TO_BIRTH": -24260.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/7/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 103.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.99135352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.99135352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 38.99135352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 38.99135352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-SY-A9G5-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "SY", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3296, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 31.0, "TISSUE_SOURCE_SITE": "Mayo Clinic Arizona", "TBL_SCORE": 245.0 }, "treatments": [ { "START_DATE": 83, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 83, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-C4-A0F1": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "ab20d2d5-ea10-4aba-b495-fbe7b18bb394", "AGE": 71, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 89.0, "DAYS_TO_BIRTH": -26178.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": 82.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.925995332, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.925995332, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.925995332, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-C4-A0F1-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "C4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2847, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.166666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 484.0 }, "treatments": [] }, "TCGA-FJ-A871": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "BB38805E-2CCC-4169-BA01-34B98ADF5BD0", "AGE": 49, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -18051.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/6/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 78.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 8.942367755, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 8.942367755, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 3.484893316, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FJ-A871-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FJ", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3077, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.5, "TISSUE_SOURCE_SITE": "BLN - Baylor", "TBL_SCORE": 27.0 }, "treatments": [ { "START_DATE": 84, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 84, "STOP_DATE": 205.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 113, "STOP_DATE": 205.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 113, "STOP_DATE": 205.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vinblastine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 113, "STOP_DATE": 189.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-4Z-AA7M": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "1ECFDF16-F5E9-4A08-8834-37F4B474179D", "AGE": 65, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 495.0, "DAYS_TO_BIRTH": -23817.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/21/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 69.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.27379426, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.27379426, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.27379426, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.27379426, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-4Z-AA7M-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "4Z", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3448, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 16.0, "TISSUE_SOURCE_SITE": "Barretos Cancer Hospital", "TBL_SCORE": 235.0 }, "treatments": [] }, "TCGA-XF-A9SX": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "A648D9BF-CF37-41FC-9515-E8F5AC85FCD4", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -23349.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/5/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 56.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 23.63809712, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 23.63809712, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 15.61626722, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9SX-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3302, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.333333333, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 78.0 }, "treatments": [ { "START_DATE": 136, "STOP_DATE": 348.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 136, "STOP_DATE": 348.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Platinum", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-4Z-AA7W": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "821B99BC-7E14-45B9-898D-6E8E149BC8A7", "AGE": 55, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 840.0, "DAYS_TO_BIRTH": -20424.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/1/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 67.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.61613571, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.61613571, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 24.98602755, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 24.98602755, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-4Z-AA7W-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "4Z", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3296, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 17.3, "TISSUE_SOURCE_SITE": "Barretos Cancer Hospital", "TBL_SCORE": 204.0 }, "treatments": [] }, "TCGA-BT-A20V": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "24f21425-b001-4986-aedf-5b4dd851c6ad", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -21551.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 5.062958214, "DSS_STATUS": null, "DSS_MONTHS": 5.062958214, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 5.062958214, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-BT-A20V-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3292, "MSI_SENSOR_SCORE": 0.39, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.3, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 211.0 }, "treatments": [] }, "TCGA-XF-A9SU": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "42BCF1A7-2F3A-4ED8-A41D-CDD67E65B928", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -27068.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/28/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 56.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 5.983496071, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 5.983496071, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 3.38626426, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9SU-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3239, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.866666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 135.0 }, "treatments": [ { "START_DATE": 137, "STOP_DATE": 137.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 137, "STOP_DATE": 137.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 107, "STOP_DATE": 117.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "radiographic progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 10.0, "RADIATION_DOSAGE": 30.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-XF-A9SK": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "03F588D6-832E-47D8-A9C4-AF6640A1A635", "AGE": 65, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -24019.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/25/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 90.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 15.97790709, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 15.97790709, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 12.55876648, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9SK-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3411, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.566666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 213.0 }, "treatments": [ { "START_DATE": 142, "STOP_DATE": 304.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 142, "STOP_DATE": 304.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BT-A20Q": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "419deaac-ea45-4bdd-9fa0-b5cd8429b44f", "AGE": 73, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -26778.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 19.49567676, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 19.49567676, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 19.49567676, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A20Q-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2936, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.0, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 78.0 }, "treatments": [] }, "TCGA-UY-A78N": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "573E124F-98CB-4014-B9D2-0499F7FBDB7A", "AGE": 80, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -29132.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 75.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 86.82644574, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 86.82644574, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 81.27034224, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-UY-A78N-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "UY", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3186, "MSI_SENSOR_SCORE": 0.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.9, "TISSUE_SOURCE_SITE": "University of California San Francisco", "TBL_SCORE": 240.0 }, "treatments": [] }, "TCGA-CU-A0YO": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "4a9ef220-922c-49cf-bbed-d173b214ed31", "AGE": 84, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -30817.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 4.898576454, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 4.898576454, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 3.879409541, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-CU-A0YO-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "CU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2791, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.066666667, "TISSUE_SOURCE_SITE": "UNC", "TBL_SCORE": 28.0 }, "treatments": [] }, "TCGA-FD-A3SP": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "5F99DCFF-D809-4C87-8024-C9B30BD565E9", "AGE": 60, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 783.0, "DAYS_TO_BIRTH": -22005.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/16/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 96.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.74218365, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.74218365, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.74218365, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.74218365, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A3SP-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3293, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.566666667, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 164.0 }, "treatments": [ { "START_DATE": 62, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vinblastine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 62, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 62, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 62, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-XF-A9SG": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "80FD5A84-4D82-49AB-BA78-9636F1989FCA", "AGE": 81, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1479.0, "DAYS_TO_BIRTH": -29825.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/4/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 85.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 48.62412467, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 48.62412467, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 48.62412467, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 48.62412467, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-XF-A9SG-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3373, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.966666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 101.0 }, "treatments": [] }, "TCGA-ZF-AA4W": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "63443198-4FCF-40BD-BEFB-4A6920D29CA4", "AGE": 56, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -20611.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 96.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 60.16372423, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 60.16372423, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 55.19939508, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 55.19939508, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-AA4W-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4141, "MSI_SENSOR_SCORE": 1.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 16.76666667, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 66.0 }, "treatments": [] }, "TCGA-G2-A2EJ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "C6227D39-D9E8-4E28-9E70-D7F720AB25E4", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1460.0, "DAYS_TO_BIRTH": -20649.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 65.3, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 47.99947398, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 47.99947398, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 29.91748036, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 29.91748036, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-G2-A2EJ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "G2", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.29, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 18.0, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 129.0 }, "treatments": [ { "START_DATE": 38, "STOP_DATE": 38.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 38, "STOP_DATE": 38.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Sodium Mercaptoetansolfonato", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "chemoprotectant", "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 38, "STOP_DATE": 38.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 38, "STOP_DATE": 38.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Ifosfamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-GV-A3JW": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "3D644EAF-82FC-4BC7-93B7-3E600E8C6511", "AGE": 74, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 649.0, "DAYS_TO_BIRTH": -27091.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/30/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 88.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.33675247, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.33675247, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.909491403, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GV-A3JW-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GV", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3304, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.4, "TISSUE_SOURCE_SITE": "BLN - Cleveland Clinic", "TBL_SCORE": 339.0 }, "treatments": [ { "START_DATE": 291, "STOP_DATE": 321.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 291, "STOP_DATE": 321.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 321, "STOP_DATE": 321.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-XF-A9SJ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "B319798A-3F35-4902-8ECF-5BE529D99312", "AGE": 83, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -30362.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/2/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 95.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 3.2218825, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 3.2218825, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 3.2218825, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9SJ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3337, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.7, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 123.0 }, "treatments": [] }, "TCGA-XF-AAME": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "C8388AC0-975D-4F1E-8324-8CABDC75738D", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -23448.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/11/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 67.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 92.97432357, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 92.97432357, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 54.27885722, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-XF-AAME-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3473, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 2569, "STOP_DATE": 2569.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 2500, "STOP_DATE": 2543.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 2500, "STOP_DATE": 2543.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1821, "STOP_DATE": 1871.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 45.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 2569, "STOP_DATE": 2613.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 60.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-CF-A3MI": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "F1EBF96B-8DF9-4E59-ACEF-7AD433E40214", "AGE": 62, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 370.0, "DAYS_TO_BIRTH": -22716.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/6/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 62.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.16425026, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.16425026, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.16425026, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.16425026, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A3MI-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3577, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.1, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 75.0 }, "treatments": [] }, "TCGA-FD-A5BU": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "980C7214-F708-4499-818D-F3DE87DC6DE7", "AGE": 76, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 588.0, "DAYS_TO_BIRTH": -27882.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/1/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 65.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.331295, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.331295, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.331295, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.331295, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-FD-A5BU-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3213, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.333333333, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 66.0 }, "treatments": [] }, "TCGA-UY-A78M": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "069B6E47-012C-483E-BEE4-36A2A21A3486", "AGE": 81, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -29706.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": null, "WEIGHT": 55.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 22.68468291, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 22.68468291, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 22.68468291, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-UY-A78M-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "UY", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3309, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.9, "TISSUE_SOURCE_SITE": "University of California San Francisco", "TBL_SCORE": 148.0 }, "treatments": [] }, "TCGA-DK-A3X1": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "6BDDAFDE-7004-49B6-80CF-8081CD4B7D44", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2009.0, "DAYS_TO_BIRTH": -28757.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/31/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.1", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 66.04859125, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 66.04859125, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 66.04859125, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 66.04859125, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A3X1-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3336, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 26.1, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 221.0 }, "treatments": [] }, "TCGA-DK-AA76": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "D37B0460-EFA4-4CF5-8082-F27FF2CF2F28", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 366.0, "DAYS_TO_BIRTH": -23542.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/8/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 85.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.03274485, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.03274485, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.03274485, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.03274485, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-AA76-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3349, "MSI_SENSOR_SCORE": 0.13, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.633333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 307.0 }, "treatments": [ { "START_DATE": 54, "STOP_DATE": 114.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 54, "STOP_DATE": 114.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-K4-A3WU": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "9AA6522A-120A-4691-993E-3F8534F644B5", "AGE": 87, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 105.0, "DAYS_TO_BIRTH": -32134.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/8/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 71.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 3.452016964, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 3.452016964, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 3.452016964, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-K4-A3WU-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "K4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3345, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.0, "TISSUE_SOURCE_SITE": "ABS - Lahey Clinic", "TBL_SCORE": 126.0 }, "treatments": [] }, "TCGA-XF-AAMX": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "EDC290BF-9731-4F03-BC37-64542E78E8BB", "AGE": 87, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -31884.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/14/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 77.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 6.77252852, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 6.77252852, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 6.77252852, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 6.77252852, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-XF-AAMX-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3598, "MSI_SENSOR_SCORE": 0.97, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.0, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 551.0 }, "treatments": [] }, "TCGA-GV-A40E": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "AA6142AF-BAD7-493C-98A0-FD070DE39073", "AGE": 75, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 195.0, "DAYS_TO_BIRTH": -27569.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/27/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 115.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 8.580727882, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 8.580727882, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.199921097, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GV-A40E-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GV", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3372, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.733333333, "TISSUE_SOURCE_SITE": "BLN - Cleveland Clinic", "TBL_SCORE": 276.0 }, "treatments": [ { "START_DATE": 56, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 56, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 231, "STOP_DATE": 244.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "radiographic progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 10.0, "RADIATION_DOSAGE": 3000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-GU-A763": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "F632BC31-3AA0-4783-B10B-818ECB26D40B", "AGE": 72, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 997.0, "DAYS_TO_BIRTH": -26527.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/19/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 73.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.77772298, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.77772298, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 9.961534668, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GU-A763-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3114, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "BLN - UT Southwestern Medical Center at Dallas", "TBL_SCORE": 24.0 }, "treatments": [] }, "TCGA-DK-A3IK": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "3F0A0748-9ACC-4D0B-BA18-7C08BD183F86", "AGE": 87, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 67.0, "DAYS_TO_BIRTH": -32076.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/10/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 91.2, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 4.799947398, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 4.799947398, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 4.799947398, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A3IK-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3076, "MSI_SENSOR_SCORE": 0.13, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.533333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 258.0 }, "treatments": [] }, "TCGA-DK-A3X2": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "40551D53-388B-4067-9341-76E94D023703", "AGE": 85, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -31160.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/31/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 17.98336457, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 17.98336457, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 17.52309564, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A3X2-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3177, "MSI_SENSOR_SCORE": 0.77, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.066666667, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 173.0 }, "treatments": [] }, "TCGA-CF-A47X": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "82D5F37F-5A1B-49D8-B990-AC222B4E1C1D", "AGE": 60, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 384.0, "DAYS_TO_BIRTH": -22200.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/11/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": 62.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.62451918, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.62451918, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.62451918, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.62451918, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A47X-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3251, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.766666667, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 36.0 }, "treatments": [ { "START_DATE": 87, "STOP_DATE": 131.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 45.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-4Z-AA80": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "5DF620FA-44D9-4361-91D0-F242E3E5E595", "AGE": 73, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -26873.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/5/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 92.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 0.624650689, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.624650689, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.624650689, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-4Z-AA80-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "4Z", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3335, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 12.66666667, "TISSUE_SOURCE_SITE": "Barretos Cancer Hospital", "TBL_SCORE": 409.0 }, "treatments": [] }, "TCGA-ZF-AA4R": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "B36E3B5F-8904-4722-ADAE-B00812EFEC65", "AGE": 67, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -24537.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 112.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 34.05990071, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 34.05990071, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 24.65726403, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-AA4R-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3355, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.1, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 94.0 }, "treatments": [] }, "TCGA-DK-A1AB": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "f027d254-ec01-4882-a8a7-964ae90b7d49", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 271.0, "DAYS_TO_BIRTH": -27126.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 89.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 16.70118684, "DSS_STATUS": null, "DSS_MONTHS": 16.70118684, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.96699214, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A1AB-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2863, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.966666667, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 15.0 }, "treatments": [] }, "TCGA-XF-AAN4": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "B6C36037-56B1-4957-8DF8-FDA72B0D3C39", "AGE": 77, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -28302.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/20/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 59.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 27.05723773, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.05723773, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 27.05723773, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.05723773, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-AAN4-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3224, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 61.0 }, "treatments": [] }, "TCGA-FD-A6TI": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "0F956645-35AA-4A68-98D3-EA589459BE00", "AGE": 73, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 122.0, "DAYS_TO_BIRTH": -26874.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/5/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 109.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 9.6656475, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.6656475, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.6656475, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A6TI-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3203, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.866666667, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 11.0 }, "treatments": [] }, "TCGA-S5-A6DX": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "76400A3D-45C4-47F8-BD81-0A345A949A1F", "AGE": 83, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -30594.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/20/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 92.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 1.841075714, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 1.841075714, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 1.841075714, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-S5-A6DX-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "S5", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3246, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 20.06666667, "TISSUE_SOURCE_SITE": "University of Oklahoma HSC", "TBL_SCORE": 212.0 }, "treatments": [] }, "TCGA-XF-A9T0": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "5F5C1775-A908-483D-8A77-B902C5B7570E", "AGE": 68, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 799.0, "DAYS_TO_BIRTH": -25190.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/28/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 82.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.26820528, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 26.26820528, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 26.26820528, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 26.26820528, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9T0-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3307, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 22.76666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 207.0 }, "treatments": [] }, "TCGA-MV-A51V": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "D2F329B3-5B44-414B-BCCD-7B2D1345D21E", "AGE": 75, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 410.0, "DAYS_TO_BIRTH": -27430.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/14/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 120.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.47930434, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.47930434, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.47930434, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.47930434, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-MV-A51V-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "MV", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2968, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 47.6, "TISSUE_SOURCE_SITE": "University of Minnesota", "TBL_SCORE": 227.0 }, "treatments": [] }, "TCGA-FT-A61P": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "7C698A35-7694-47F0-B681-F08840B95C02", "AGE": 76, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 337.0, "DAYS_TO_BIRTH": -28082.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/22/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 88.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.07933064, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.07933064, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.07933064, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FT-A61P-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.308, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.866666667, "TISSUE_SOURCE_SITE": "BLN - University of Miami", "TBL_SCORE": 88.0 }, "treatments": [] }, "TCGA-UY-A9PB": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "F90CFF19-1C16-4514-8BC1-169539D01FCA", "AGE": 49, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 899.0, "DAYS_TO_BIRTH": -17885.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/1/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 133.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.55584048, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.55584048, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.55584048, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.55584048, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-UY-A9PB-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "UY", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3303, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 16.73333333, "TISSUE_SOURCE_SITE": "University of California San Francisco", "TBL_SCORE": 133.0 }, "treatments": [] }, "TCGA-UY-A8OD": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "FA2410B1-4F69-446D-99EE-A10A00034C42", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3432.0, "DAYS_TO_BIRTH": -24588.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/18/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 112.8316402, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 112.8316402, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 112.8316402, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 112.8316402, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-UY-A8OD-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "UY", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3321, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.933333333, "TISSUE_SOURCE_SITE": "University of California San Francisco", "TBL_SCORE": 96.0 }, "treatments": [] }, "TCGA-DK-A1AD": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "88a521ce-a5e9-4c6f-83d4-ec36a62fedb6", "AGE": 69, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 3420.0, "DAYS_TO_BIRTH": -25317.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 80.7, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 112.437124, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 112.437124, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 112.437124, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A1AD-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2888, "MSI_SENSOR_SCORE": 0.5, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.433333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 323.0 }, "treatments": [] }, "TCGA-XF-AAMR": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "818F5A45-4DEB-49E4-9A73-55EF4269DE4C", "AGE": 48, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2790.0, "DAYS_TO_BIRTH": -17670.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/13/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 79.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 91.72502219, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 91.72502219, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 91.72502219, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 91.72502219, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-AAMR-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3313, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.066666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 76.0 }, "treatments": [ { "START_DATE": 119, "STOP_DATE": 192.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 119, "STOP_DATE": 192.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-UY-A8OC": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "5A0E4DC3-4EC6-4D27-BB7E-1D2221D06D33", "AGE": 90, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -32918.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 3.024624388, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 3.024624388, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 1.052043265, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-UY-A8OC-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "UY", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3411, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.9, "TISSUE_SOURCE_SITE": "University of California San Francisco", "TBL_SCORE": 129.0 }, "treatments": [] }, "TCGA-CF-A47V": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "E5086EAB-C920-4E3E-A965-90F3F495363A", "AGE": 52, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 379.0, "DAYS_TO_BIRTH": -19265.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/11/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": 59.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.46013742, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.46013742, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.46013742, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.46013742, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A47V-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3274, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.2, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 51.0 }, "treatments": [ { "START_DATE": 32, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 45.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-4Z-AA87": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "45B4B153-E4AA-4080-B0DC-EE81A966978A", "AGE": 72, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1454.0, "DAYS_TO_BIRTH": -26430.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/5/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 52.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 47.80221587, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 47.80221587, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.265673801, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-4Z-AA87-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "4Z", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3459, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.7, "TISSUE_SOURCE_SITE": "Barretos Cancer Hospital", "TBL_SCORE": 517.0 }, "treatments": [] }, "TCGA-CF-A9FH": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "83A369AE-003B-432B-A7B2-C630805B43C1", "AGE": 85, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": -64.0, "DAYS_TO_BIRTH": -31236.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/30/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 58.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.0, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.0, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.0, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.0, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A9FH-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.328, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.266666667, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 18.0 }, "treatments": [] }, "TCGA-K4-A83P": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "AA14FFB4-A715-4636-8251-73D019DDDD8C", "AGE": 77, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 495.0, "DAYS_TO_BIRTH": -28463.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/6/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 100.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.27379426, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.27379426, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 2.301344643, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-K4-A83P-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": null, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": null, "TISSUE_SOURCE_SITE_CODE": "K4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 29.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3253, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 15.53333333, "TISSUE_SOURCE_SITE": "ABS - Lahey Clinic", "TBL_SCORE": 51.0 }, "treatments": [] }, "TCGA-FD-A5C1": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "070C66FA-EF48-46CB-AF4F-357D2C641118", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1792.0, "DAYS_TO_BIRTH": -22505.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/2/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 104.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 58.91442286, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 58.91442286, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 58.91442286, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 58.91442286, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A5C1-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.32, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.4, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 62.0 }, "treatments": [ { "START_DATE": 1421, "STOP_DATE": 1491.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1421, "STOP_DATE": 1491.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FD-A62P": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "741311B6-CB15-498F-932D-CA282E1DB10D", "AGE": 76, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -27843.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/21/2013", "HISTORY_NEOADJUVANT_TRTYN": "Yes", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 110.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 6.27938324, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 6.27938324, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 6.27938324, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A62P-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3055, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 12.03333333, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 142.0 }, "treatments": [] }, "TCGA-FD-A62O": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "472502EB-AD99-4A1A-8445-1A11DC02A6D9", "AGE": 74, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 147.0, "DAYS_TO_BIRTH": -27310.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/21/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 65.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 7.101292041, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.101292041, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 7.101292041, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A62O-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3186, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.5, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 25.0 }, "treatments": [] }, "TCGA-YF-AA3M": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "30AD8081-DAA7-4E2B-96F8-07F5AD12E774", "AGE": 57, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 415.0, "DAYS_TO_BIRTH": -21097.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/23/2014", "HISTORY_NEOADJUVANT_TRTYN": "Yes", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "Yes", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 77.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.6436861, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.6436861, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 12.52589013, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 12.52589013, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-YF-AA3M-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "YF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3537, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.633333333, "TISSUE_SOURCE_SITE": "University of Puerto Rico", "TBL_SCORE": 145.0 }, "treatments": [] }, "TCGA-ZF-AA4U": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "585DFB25-5013-4AE1-A26B-5FED08E6CDB3", "AGE": 70, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -25682.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 95.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 8.613604235, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 8.613604235, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 6.542394056, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-AA4U-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3297, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.8, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 96.0 }, "treatments": [] }, "TCGA-K4-A54R": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "52FDDD92-FA5E-4FAC-8E44-E64C98C84F86", "AGE": 59, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 842.0, "DAYS_TO_BIRTH": -21601.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/17/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.1", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.68188842, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.68188842, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 27.68188842, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.68188842, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-K4-A54R-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "K4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3101, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 55.83333333, "TISSUE_SOURCE_SITE": "ABS - Lahey Clinic", "TBL_SCORE": 46.0 }, "treatments": [] }, "TCGA-BT-A20T": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "096b4f32-10c1-4737-a0dd-cae04c54ee33", "AGE": 63, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -23220.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 14.89298747, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 14.89298747, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.32317454, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A20T-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2993, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.966666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 127.0 }, "treatments": [ { "START_DATE": 161, "STOP_DATE": 263.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 161, "STOP_DATE": 263.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 263, "STOP_DATE": 331.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 263, "STOP_DATE": 331.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Oxaliplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 419, "STOP_DATE": 419.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FD-A5BT": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "CC2350CA-9220-400D-8B76-CC36D26F68D6", "AGE": 84, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -30686.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/1/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 80.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 10.78344347, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.78344347, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.78344347, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A5BT-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2999, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.666666667, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 68.0 }, "treatments": [] }, "TCGA-BT-A20X": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "be8b3f36-aaa1-4302-b28e-de1996faceaf", "AGE": 56, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -20519.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.1", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 8.251964362, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 8.251964362, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.251964362, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A20X-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3094, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.3, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 41.0 }, "treatments": [] }, "TCGA-FD-A5BR": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "DFDAEBD6-E0AB-49D1-9AE9-3A57B3C318B5", "AGE": 57, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 813.0, "DAYS_TO_BIRTH": -20964.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/1/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 121.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.72847421, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 26.72847421, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 26.72847421, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 26.72847421, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A5BR-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2946, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.9, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 47.0 }, "treatments": [] }, "TCGA-G2-A3IB": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "AF53D51E-0B5C-437F-A1C0-EC5F55C49364", "AGE": 66, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 214.0, "DAYS_TO_BIRTH": -24149.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/22/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 83.6, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 7.232797449, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 7.232797449, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.232797449, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-G2-A3IB-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "G2", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3417, "MSI_SENSOR_SCORE": 0.3, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.866666667, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 43.0 }, "treatments": [ { "START_DATE": 143, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 143, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 143, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 143, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vinblastine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-XF-A8HG": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "B9B61CF9-8711-4C3A-8511-659070CFE36B", "AGE": 69, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -25421.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/5/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 108.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 15.3532564, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 15.3532564, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 13.08478811, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 13.08478811, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A8HG-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 28.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4143, "MSI_SENSOR_SCORE": 1.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.1, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 75.0 }, "treatments": [] }, "TCGA-4Z-AA89": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "604C0D60-6BA9-4D2F-98DB-E310C58BC8CA", "AGE": 60, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 902.0, "DAYS_TO_BIRTH": -22271.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/1/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.82976625, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.82976625, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 21.30387612, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-4Z-AA89-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "4Z", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3261, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.166666667, "TISSUE_SOURCE_SITE": "Barretos Cancer Hospital", "TBL_SCORE": 37.0 }, "treatments": [] }, "TCGA-G2-AA3B": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "22424A05-0546-44C2-8AB7-ABB8E49C3363", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2008.0, "DAYS_TO_BIRTH": -27646.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/11/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 76.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 66.0157149, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 66.0157149, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 66.0157149, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 66.0157149, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-G2-AA3B-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "G2", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3217, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 22.1, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 351.0 }, "treatments": [] }, "TCGA-XF-AAMJ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "8F10E006-531A-49AC-B51B-DF3FDCB20929", "AGE": 70, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -25838.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/12/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": 55.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 54.90350791, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 54.90350791, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 54.90350791, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 54.90350791, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-XF-AAMJ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3403, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 56.0 }, "treatments": [ { "START_DATE": 82, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 82, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Platinum", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 173, "STOP_DATE": 204.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-2F-A9KP": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "65D1EAEC-28DB-4A41-A4DB-1A710FCB24AD", "AGE": 66, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -24428.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/19/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 130.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 11.96699214, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 11.96699214, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.27658875, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-2F-A9KP-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "2F", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3234, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.4, "TISSUE_SOURCE_SITE": "Erasmus MC", "TBL_SCORE": 270.0 }, "treatments": [] }, "TCGA-ZF-A9R4": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "371B5D70-9797-4DAE-B523-247F5EAEB4AB", "AGE": 83, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 921.0, "DAYS_TO_BIRTH": -30398.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 30.27912023, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 30.27912023, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 30.27912023, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 30.27912023, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-A9R4-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3277, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.7, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 96.0 }, "treatments": [] }, "TCGA-BT-A0YX": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "22473ad4-df39-4716-b558-3c1409d5fa0e", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 363.0, "DAYS_TO_BIRTH": -25570.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 13.15054082, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 13.15054082, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.71769077, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A0YX-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2734, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 19.76666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 35.0 }, "treatments": [] }, "TCGA-GV-A3JZ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "9CC92795-7A24-4875-87F0-3EFCCBFCC970", "AGE": 55, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 603.0, "DAYS_TO_BIRTH": -20420.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/30/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 84.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.82444028, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.82444028, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.82444028, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GV-A3JZ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GV", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2047, "MSI_SENSOR_SCORE": 0.51, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.1, "TISSUE_SOURCE_SITE": "BLN - Cleveland Clinic", "TBL_SCORE": 360.0 }, "treatments": [ { "START_DATE": 529, "STOP_DATE": 589.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": null, "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "chemotherapy", "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-ZF-A9RL": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "386F51E4-D03A-4606-BF2E-6168F2122C5F", "AGE": 61, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2703.0, "DAYS_TO_BIRTH": -22480.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 88.86477956, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 88.86477956, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 34.98043857, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 34.98043857, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-A9RL-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3199, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.43333333, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 81.0 }, "treatments": [] }, "TCGA-XF-A9SZ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "DC321B92-7275-48C9-ADEB-7670DB3195EF", "AGE": 79, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -29100.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/27/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 77.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 28.2407864, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 28.2407864, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 28.07640464, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9SZ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3208, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.766666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 134.0 }, "treatments": [ { "START_DATE": 97, "STOP_DATE": 169.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 97, "STOP_DATE": 169.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-K4-A5RJ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "5A25658C-2436-4A47-8902-8A2CF4A1C20D", "AGE": 75, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 539.0, "DAYS_TO_BIRTH": -27518.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/24/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.72035375, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.72035375, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.72035375, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.72035375, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-K4-A5RJ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "K4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3069, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.7, "TISSUE_SOURCE_SITE": "ABS - Lahey Clinic", "TBL_SCORE": 56.0 }, "treatments": [] }, "TCGA-XF-AAN1": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "5378F375-AA04-4ECA-BC35-190B3EFB52BC", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -27687.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/16/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 92.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 30.93664727, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 30.93664727, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 21.36962883, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-XF-AAN1-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3411, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.366666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 79.0 }, "treatments": [ { "START_DATE": 0, "STOP_DATE": 0.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bacillus Calmette-Guerin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 0, "STOP_DATE": 0.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bacillus Calmette-Guerin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-GU-AATP": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "3B16881A-88C2-4048-B78F-E3E183503F70", "AGE": 74, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1003.0, "DAYS_TO_BIRTH": -27049.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/25/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 118.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.9749811, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.9749811, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 19.59430582, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GU-AATP-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3245, "MSI_SENSOR_SCORE": 0.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.966666667, "TISSUE_SOURCE_SITE": "BLN - UT Southwestern Medical Center at Dallas", "TBL_SCORE": 158.0 }, "treatments": [] }, "TCGA-XF-A8HB": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "90BF49B7-6710-4665-82DF-30ECC22C59A3", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1370.0, "DAYS_TO_BIRTH": -18544.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/4/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 73.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 45.0406023, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 45.0406023, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 45.0406023, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 45.0406023, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-XF-A8HB-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.325, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.333333333, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 64.0 }, "treatments": [] }, "TCGA-E7-A3X6": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "C871EA6B-FBD2-4E6F-AB29-F43F6E3DDCBB", "AGE": 70, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 750.0, "DAYS_TO_BIRTH": -25584.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/14/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 89.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 29.72022224, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 29.72022224, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 12.1313739, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 12.1313739, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E7-A3X6-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3159, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.6, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 77.0 }, "treatments": [ { "START_DATE": 369, "STOP_DATE": 407.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 58.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 620, "STOP_DATE": 662.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 50.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-CF-A7I0": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "25AC9ACD-328B-4FAE-A448-4F3957B1B212", "AGE": 54, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 368.0, "DAYS_TO_BIRTH": -20059.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/3/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 56.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.09849755, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.09849755, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.09849755, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.09849755, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A7I0-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3211, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 65.0 }, "treatments": [] }, "TCGA-CU-A3KJ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "A75584BC-BEF7-48F6-B4B3-C1472A3AF768", "AGE": 75, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 562.0, "DAYS_TO_BIRTH": -27692.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/19/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 75.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.47650985, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.47650985, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 5.457474439, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-CU-A3KJ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2424, "MSI_SENSOR_SCORE": 0.35, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.766666667, "TISSUE_SOURCE_SITE": "UNC", "TBL_SCORE": 187.0 }, "treatments": [] }, "TCGA-DK-A3IV": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "F953DC5D-58BF-4936-B9FE-74B45E8C00E5", "AGE": 60, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -22237.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 85.4, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 9.6656475, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 9.6656475, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 6.969786633, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A3IV-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.337, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.533333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 78.0 }, "treatments": [ { "START_DATE": 17, "STOP_DATE": 87.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 17, "STOP_DATE": 87.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DK-A1AG": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "f8c0a69c-df53-4a0a-a30e-4424c0ce3dd5", "AGE": 65, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 475.0, "DAYS_TO_BIRTH": -24095.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 94.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.61626722, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.61626722, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.61626722, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.61626722, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A1AG-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2822, "MSI_SENSOR_SCORE": 0.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.7, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 36.0 }, "treatments": [] }, "TCGA-BT-A20O": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "c0e7fbe7-b9cb-4e65-941b-cd7d581c54ec", "AGE": 75, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -27534.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 12.16425026, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 12.16425026, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.35605089, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A20O-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2813, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.766666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 19.0 }, "treatments": [] }, "TCGA-FT-A3EE": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "CCE62116-3DCD-400D-ADA0-9839CA02466E", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -29293.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.5", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.5", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 77.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 3.254758852, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 3.254758852, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 3.254758852, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-FT-A3EE-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3404, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.9, "TISSUE_SOURCE_SITE": "BLN - University of Miami", "TBL_SCORE": 42.0 }, "treatments": [] }, "TCGA-BL-A0C8": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "a6003b1c-56a9-430a-a5e2-b70af3f81bdb", "AGE": 73, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1219.0, "DAYS_TO_BIRTH": -26819.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.1", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 134.4, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 40.07627314, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 40.07627314, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 20.71210179, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 20.71210179, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BL-A0C8-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Bladder Urothelial Carcinoma", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BL", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2942, "MSI_SENSOR_SCORE": 1.5, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.666666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 264.7 }, "treatments": [ { "START_DATE": 680, "STOP_DATE": 722.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bacillus Calmette-Guerin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FD-A3B4": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "899F8D52-4C3A-4371-90EB-1F106001EDDC", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 477.0, "DAYS_TO_BIRTH": -20379.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/13/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 16.76693954, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 16.76693954, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 11.80261038, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.80261038, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-FD-A3B4-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3016, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.4, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 56.0 }, "treatments": [ { "START_DATE": 115, "STOP_DATE": 157.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 115, "STOP_DATE": 157.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FD-A5BY": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "8DA76432-3004-47E5-A474-BD94BD4C0B33", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 251.0, "DAYS_TO_BIRTH": -23080.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/2/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 73.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 8.251964362, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 8.251964362, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 8.251964362, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 8.251964362, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A5BY-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 28.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3094, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.5, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 37.0 }, "treatments": [] }, "TCGA-FD-A3N5": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "A658BECF-3934-49F2-9E74-291DCA61D4BB", "AGE": 69, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 363.0, "DAYS_TO_BIRTH": -25342.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/21/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 22.52030115, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 22.52030115, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.37521781, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-FD-A3N5-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2433, "MSI_SENSOR_SCORE": 4.96, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.3, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 96.0 }, "treatments": [] }, "TCGA-CF-A9FL": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "96292F0E-5D09-4C44-8DFC-73EBDE6BF137", "AGE": 85, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 84.0, "DAYS_TO_BIRTH": -31099.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/30/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "Yes", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 45.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 18.5751389, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 18.5751389, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 10.58618536, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.58618536, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A9FL-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3227, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.9, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 32.0 }, "treatments": [] }, "TCGA-XF-A9T8": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "317E1DB6-DF93-4793-A4DF-2FA234D8A81A", "AGE": 64, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -23403.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/5/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 87.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 13.74231515, "DSS_STATUS": null, "DSS_MONTHS": 13.74231515, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.74231515, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9T8-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3155, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 21.56666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 161.0 }, "treatments": [] }, "TCGA-BL-A3JM": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "0F4FB205-B13C-4A85-97B3-779429E6CCDD", "AGE": 62, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -23000.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/26/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 86.36, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 6.739652168, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 6.739652168, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 3.649275076, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BL-A3JM-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BL", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3391, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.033333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 26.0 }, "treatments": [ { "START_DATE": 140, "STOP_DATE": 142.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2400.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DK-A2I4": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "5C4AEBEB-FB6F-4D66-B24A-89EF20DE971E", "AGE": 79, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 4343.0, "DAYS_TO_BIRTH": -29037.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/10/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 104.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 142.7819969, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 142.7819969, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 142.7819969, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 142.7819969, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A2I4-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2236, "MSI_SENSOR_SCORE": 0.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 26.83333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 76.0 }, "treatments": [] }, "TCGA-CF-A27C": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "7fee9d6f-c0ea-43c2-89c2-66d965a077a8", "AGE": 52, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 425.0, "DAYS_TO_BIRTH": -19270.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": 59.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.97244962, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.97244962, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.97244962, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.97244962, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A27C-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3175, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.4, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 47.0 }, "treatments": [ { "START_DATE": 50, "STOP_DATE": 89.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 35.0, "RADIATION_DOSAGE": 70.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-E7-A5KF": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "5D06CC19-8B10-4ED1-B6D4-8E044F1F8A8C", "AGE": 67, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 20.0, "DAYS_TO_BIRTH": -24528.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/12/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": null, "WEIGHT": 57.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.657527041, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.657527041, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.657527041, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-E7-A5KF-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3095, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.766666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 12.0 }, "treatments": [] }, "TCGA-4Z-AA84": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "8B091AC3-D03A-4DD2-BDDE-F7F5C6987155", "AGE": 61, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 460.0, "DAYS_TO_BIRTH": -22397.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/21/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 63.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.12312194, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.12312194, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.12312194, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-4Z-AA84-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "4Z", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3257, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.16666667, "TISSUE_SOURCE_SITE": "Barretos Cancer Hospital", "TBL_SCORE": 510.0 }, "treatments": [] }, "TCGA-ZF-A9RG": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "1EB0ADBF-DBE8-4736-97F6-2DC4EE30E943", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1786.0, "DAYS_TO_BIRTH": -25656.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 76.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 58.71716474, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 58.71716474, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 14.4655949, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 14.4655949, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-A9RG-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.331, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.3, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 77.0 }, "treatments": [] }, "TCGA-K4-A4AC": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "2088AC24-A8B4-49AF-A954-2B78B88A6F66", "AGE": 83, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 197.0, "DAYS_TO_BIRTH": -30655.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/28/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 9.139625867, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 9.139625867, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 5.588979847, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-K4-A4AC-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "K4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.303, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.566666667, "TISSUE_SOURCE_SITE": "ABS - Lahey Clinic", "TBL_SCORE": 191.0 }, "treatments": [ { "START_DATE": 127, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "radiographic progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 20.0, "RADIATION_DOSAGE": 5040.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 176, "STOP_DATE": 187.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 10.0, "RADIATION_DOSAGE": 3000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-XF-AAMZ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "ED36D054-53C4-465C-BD84-6EC5227097BF", "AGE": 81, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -29667.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 52.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 44.31732255, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 44.31732255, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 44.18581714, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-XF-AAMZ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3312, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.866666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 263.0 }, "treatments": [ { "START_DATE": 0, "STOP_DATE": 0.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bacillus Calmette-Guerin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-PQ-A6FI": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "04B9090A-E8EF-4F52-BC52-AF90CAA84168", "AGE": 70, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 372.0, "DAYS_TO_BIRTH": -25672.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/10/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 87.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.23000296, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.23000296, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.23000296, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.23000296, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-PQ-A6FI-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "PQ", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.345, "MSI_SENSOR_SCORE": 0.6, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.766666667, "TISSUE_SOURCE_SITE": "University of Colorado Denver", "TBL_SCORE": 118.0 }, "treatments": [] }, "TCGA-DK-A6B6": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "AB6580E4-5DE9-4361-B06A-1D20E5571890", "AGE": 57, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1115.0, "DAYS_TO_BIRTH": -21007.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/6/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 103.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.65713253, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.65713253, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.65713253, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.65713253, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A6B6-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3121, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 26.66666667, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 82.0 }, "treatments": [ { "START_DATE": 43, "STOP_DATE": 113.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 43, "STOP_DATE": 113.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-GU-A764": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "20EBEFF1-E5A7-423A-BE93-E7EBB82438AC", "AGE": 66, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 610.0, "DAYS_TO_BIRTH": -24343.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/19/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 73.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.05457474, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.05457474, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.05457474, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.05457474, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GU-A764-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3302, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.866666667, "TISSUE_SOURCE_SITE": "BLN - UT Southwestern Medical Center at Dallas", "TBL_SCORE": 124.0 }, "treatments": [] }, "TCGA-GU-AATO": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "CD20B968-B348-44EB-9CDB-F557AF8FB468", "AGE": 75, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -27684.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/25/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 10.65193806, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 10.65193806, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.65193806, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GU-AATO-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3243, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.766666667, "TISSUE_SOURCE_SITE": "BLN - UT Southwestern Medical Center at Dallas", "TBL_SCORE": 123.0 }, "treatments": [] }, "TCGA-XF-AAN5": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "C1591625-E794-4155-8AE4-B74D6264659F", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2293.0, "DAYS_TO_BIRTH": -22411.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/20/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 56.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 75.38547523, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 75.38547523, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 75.38547523, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 75.38547523, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-AAN5-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3505, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.8, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 43.0 }, "treatments": [ { "START_DATE": 127, "STOP_DATE": 211.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 127, "STOP_DATE": 211.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DK-A6AV": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "B41DF0B0-572E-4DDB-9F1D-1B69DD1AD290", "AGE": 82, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1952.0, "DAYS_TO_BIRTH": -30089.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/6/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.1", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 55.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 64.17463918, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 64.17463918, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 64.17463918, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 64.17463918, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-DK-A6AV-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3242, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.466666667, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 215.0 }, "treatments": [] }, "TCGA-ZF-AA4X": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "E6F7BF6C-92B1-4795-94FC-B189D0C7877F", "AGE": 56, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2044.0, "DAYS_TO_BIRTH": -20579.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/12/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 73.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 67.19926357, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 67.19926357, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 54.73912615, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 54.73912615, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-AA4X-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3141, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 19.5, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 28.0 }, "treatments": [ { "START_DATE": 63, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DK-A3IS": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "9F75CC89-CC3F-4AE9-973D-DA37C6417BFC", "AGE": 68, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1529.0, "DAYS_TO_BIRTH": -25098.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/13/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 83.5, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 50.26794227, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.26794227, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 50.26794227, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 50.26794227, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A3IS-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2659, "MSI_SENSOR_SCORE": 0.82, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.33333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 136.0 }, "treatments": [] }, "TCGA-FJ-A3ZF": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "FAE38579-5FE2-4D81-9729-39FDE866D18C", "AGE": 73, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 524.0, "DAYS_TO_BIRTH": -26825.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/28/2012", "HISTORY_NEOADJUVANT_TRTYN": "Yes", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 108.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.22720847, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.22720847, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.22720847, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.22720847, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FJ-A3ZF-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FJ", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.334, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.566666667, "TISSUE_SOURCE_SITE": "BLN - Baylor", "TBL_SCORE": 134.0 }, "treatments": [ { "START_DATE": 41, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 41, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-GC-A3OO": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "1FF60FD9-3CA3-43BE-92A8-8DBA2CD4D4DF", "AGE": 79, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 481.0, "DAYS_TO_BIRTH": -29065.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/25/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 130.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.81352533, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.81352533, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.81352533, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.81352533, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GC-A3OO-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GC", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3191, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.866666667, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 8.0 }, "treatments": [] }, "TCGA-LT-A8JT": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "6AA72CA1-B378-4DB4-B4EF-B12386683D1F", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 641.0, "DAYS_TO_BIRTH": -25498.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/30/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 69.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.07374166, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.07374166, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.07374166, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.07374166, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-LT-A8JT-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3335, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.366666667, "TISSUE_SOURCE_SITE": "Gundersen Lutheran Health System", "TBL_SCORE": 20.0 }, "treatments": [] }, "TCGA-BT-A20R": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "f8780a4b-7f55-41d1-bf92-8513955d150e", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -28987.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 5.062958214, "DSS_STATUS": null, "DSS_MONTHS": 5.062958214, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 5.062958214, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A20R-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3095, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.4, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 124.0 }, "treatments": [] }, "TCGA-XF-AAMY": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "9D2B19EB-BD61-490E-982B-FADF2C4AADF7", "AGE": 78, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 3011.0, "DAYS_TO_BIRTH": -28509.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 119.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 98.99069599, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 98.99069599, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 20.94223625, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 20.94223625, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-XF-AAMY-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3472, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.6, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 191.0 }, "treatments": [ { "START_DATE": 669, "STOP_DATE": 853.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 671, "STOP_DATE": 853.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BT-A42F": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "DA98BE9D-7ACF-43CE-AA24-38D1D2604506", "AGE": 64, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 864.0, "DAYS_TO_BIRTH": -23713.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/10/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 102.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 28.40516816, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.40516816, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 28.40516816, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A42F-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3106, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.566666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 50.0 }, "treatments": [] }, "TCGA-E5-A4U1": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "1C28F311-E0B0-4292-B29A-C6757665A4A4", "AGE": 72, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1181.0, "DAYS_TO_BIRTH": -26305.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/19/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 99.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.82697176, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.82697176, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 23.17782819, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 23.17782819, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E5-A4U1-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E5", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3324, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 18.5, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 254.0 }, "treatments": [ { "START_DATE": 37, "STOP_DATE": 114.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 37, "STOP_DATE": 114.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 719, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": null, "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "platinum-based antineoplastic", "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1024, "STOP_DATE": 1150.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-CU-A72E": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "AE080E88-82DA-480C-BD13-AE214DA0463C", "AGE": 76, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 284.0, "DAYS_TO_BIRTH": -27963.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/9/2013", "HISTORY_NEOADJUVANT_TRTYN": "Yes", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 137.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 13.57793339, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 13.57793339, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.416346122, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-CU-A72E-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.322, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.033333333, "TISSUE_SOURCE_SITE": "UNC", "TBL_SCORE": 44.0 }, "treatments": [] }, "TCGA-FD-A6TE": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "5C771EE8-2AEA-498D-BA8C-CDBAEBFD57AC", "AGE": 54, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 376.0, "DAYS_TO_BIRTH": -19874.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/5/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 65.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.36150837, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.36150837, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.55330901, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A6TE-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 26.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3385, "MSI_SENSOR_SCORE": 0.34, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.466666667, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 60.0 }, "treatments": [] }, "TCGA-G2-A2EO": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "98B9AD62-76ED-43E3-91BC-B8F065D79673", "AGE": 69, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1072.0, "DAYS_TO_BIRTH": -25440.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 89.2, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 59.30893908, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 59.30893908, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 59.30893908, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 59.30893908, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-G2-A2EO-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "G2", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3175, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 27.33333333, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 113.0 }, "treatments": [] }, "TCGA-HQ-A5NE": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "E053A911-2202-4C1F-BC93-904E26564E79", "AGE": 57, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 250.0, "DAYS_TO_BIRTH": -20647.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/30/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 62.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 12.16425026, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 12.16425026, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 6.93691028, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 6.93691028, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-HQ-A5NE-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "HQ", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 30.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3097, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.26666667, "TISSUE_SOURCE_SITE": "Ontario Institute for Cancer Research (OICR)", "TBL_SCORE": 65.0 }, "treatments": [ { "START_DATE": 238, "STOP_DATE": 245.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 5.0, "RADIATION_DOSAGE": 20.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-GV-A40G": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "10422FE9-8D70-40A9-9875-3FE9FAB68823", "AGE": 77, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 580.0, "DAYS_TO_BIRTH": -28204.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/27/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 82.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.06828418, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.06828418, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.06828418, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.06828418, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GV-A40G-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GV", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3349, "MSI_SENSOR_SCORE": 0.38, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.933333333, "TISSUE_SOURCE_SITE": "BLN - Cleveland Clinic", "TBL_SCORE": 160.0 }, "treatments": [] }, "TCGA-GU-A762": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "6A1EEE8D-CF62-47E9-9322-C18633CB3EE9", "AGE": 87, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 62.0, "DAYS_TO_BIRTH": -31812.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/19/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 75.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 7.627313673, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 7.627313673, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.627313673, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GU-A762-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3248, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.566666667, "TISSUE_SOURCE_SITE": "BLN - UT Southwestern Medical Center at Dallas", "TBL_SCORE": 187.0 }, "treatments": [] }, "TCGA-FD-A62N": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "B7439EDC-B7AB-407E-810A-C60864A915BF", "AGE": 69, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 82.0, "DAYS_TO_BIRTH": -25297.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/21/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": null, "WEIGHT": 84.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.695860867, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.695860867, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.695860867, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.695860867, "GENETIC_ANCESTRY_LABEL": "SAS" }, "sample": { "SAMPLE_ID": "TCGA-FD-A62N-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3062, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.8, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 45.0 }, "treatments": [] }, "TCGA-XF-AAMT": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "ADA95115-275F-4229-AA00-F298A5FF931C", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -27397.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/13/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 2.958871684, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 2.958871684, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 2.958871684, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-XF-AAMT-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3377, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.333333333, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 68.0 }, "treatments": [] }, "TCGA-E7-A678": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "29C52372-D3A7-4188-B468-67C3451C4F20", "AGE": 55, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 798.0, "DAYS_TO_BIRTH": -20169.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/28/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 55.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.23532893, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 26.23532893, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 26.23532893, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 26.23532893, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-E7-A678-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3072, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 3.0 }, "treatments": [] }, "TCGA-FD-A6TF": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "6134F549-6876-4C07-8E58-49EC87EAF4C0", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 63.0, "DAYS_TO_BIRTH": -29317.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/5/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 81.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 2.268468291, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.268468291, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.268468291, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A6TF-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3282, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.3, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 118.0 }, "treatments": [] }, "TCGA-DK-A3IM": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "41B59716-116F-4942-8B63-409870A87E26", "AGE": 76, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 238.0, "DAYS_TO_BIRTH": -28106.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 92.1, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 8.153335306, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 8.153335306, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 6.60814676, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 6.60814676, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A3IM-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3511, "MSI_SENSOR_SCORE": 0.47, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.533333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 226.0 }, "treatments": [] }, "TCGA-4Z-AA83": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "7976DBB0-57B0-463E-A766-126E23825743", "AGE": 52, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 2024.0, "DAYS_TO_BIRTH": -19280.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/21/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 101.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 66.54173653, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 66.54173653, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 66.54173653, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 66.54173653, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-4Z-AA83-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "4Z", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3215, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.533333333, "TISSUE_SOURCE_SITE": "Barretos Cancer Hospital", "TBL_SCORE": 28.0 }, "treatments": [] }, "TCGA-G2-A3VY": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "CD50C69F-0F45-4C57-B61A-8C6B41AB4F7E", "AGE": 66, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 536.0, "DAYS_TO_BIRTH": -24112.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/6/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "Yes", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 74.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.62172469, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.62172469, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.62172469, "GENETIC_ANCESTRY_LABEL": "SAS_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-G2-A3VY-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "G2", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3366, "MSI_SENSOR_SCORE": 0.46, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 22.3, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 377.0 }, "treatments": [ { "START_DATE": 210, "STOP_DATE": 210.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": null, "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-2F-A9KW": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "3B464065-B2E9-4FB2-A7DA-09E963FD43B3", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 147.0, "DAYS_TO_BIRTH": -24703.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/19/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 70.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 8.350593418, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 8.350593418, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 2.794489923, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-2F-A9KW-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "2F", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3256, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.166666667, "TISSUE_SOURCE_SITE": "Erasmus MC", "TBL_SCORE": 270.0 }, "treatments": [] }, "TCGA-CF-A47W": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "122FC134-8915-47DB-96C9-AB1853C3CD18", "AGE": 42, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 368.0, "DAYS_TO_BIRTH": -15497.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/11/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.09849755, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.09849755, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.09849755, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.09849755, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A47W-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3304, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-GU-AATQ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "AFF1533B-486E-40B5-A35A-CFAAC5823706", "AGE": 68, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -25185.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/25/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 73.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 7.002662985, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 7.002662985, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.002662985, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GU-AATQ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.339, "MSI_SENSOR_SCORE": 0.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.933333333, "TISSUE_SOURCE_SITE": "BLN - UT Southwestern Medical Center at Dallas", "TBL_SCORE": 77.0 }, "treatments": [] }, "TCGA-E7-A4XJ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "92495A89-9974-4F75-99E0-28BD11114460", "AGE": 66, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 16.0, "DAYS_TO_BIRTH": -24279.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/4/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 61.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 2.235591939, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.235591939, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.235591939, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.235591939, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-E7-A4XJ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3217, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 18.0 }, "treatments": [] }, "TCGA-DK-AA6R": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "5DB4B168-A6BA-482C-B067-2274EBA96AAD", "AGE": 68, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 5041.0, "DAYS_TO_BIRTH": -25196.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/7/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 74.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 165.7296906, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 165.7296906, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 161.3242595, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-AA6R-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3337, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.1, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 169.0 }, "treatments": [ { "START_DATE": 125, "STOP_DATE": 204.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 125, "STOP_DATE": 204.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-XF-A9SH": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "B838A4DB-EF0A-4D88-A220-BF57E31E0B3C", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -24060.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/16/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 54.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 64.79928987, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 64.79928987, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 17.98336457, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-XF-A9SH-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3284, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.266666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 78.0 }, "treatments": [ { "START_DATE": 625, "STOP_DATE": 996.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Halichondrin B", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1633, "STOP_DATE": 1680.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1759, "STOP_DATE": 1782.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Ifosfamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1759, "STOP_DATE": 1782.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1759, "STOP_DATE": 1782.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Sodium Mercaptoetansolfonato", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1187, "STOP_DATE": 1240.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 30.0, "RADIATION_DOSAGE": 5400.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-ZF-AA51": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "1029514B-A32C-4C43-A440-A5BA2709F717", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1714.0, "DAYS_TO_BIRTH": -25484.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 54.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 56.3500674, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 56.3500674, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 56.3500674, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 56.3500674, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-AA51-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3215, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 20.86666667, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 393.0 }, "treatments": [ { "START_DATE": 69, "STOP_DATE": 148.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 69, "STOP_DATE": 148.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-UY-A9PH": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "CD10DC46-356A-420B-B3F5-9E4ED4E7ECAB", "AGE": 73, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1561.0, "DAYS_TO_BIRTH": -26654.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/1/2014", "HISTORY_NEOADJUVANT_TRTYN": "Yes", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 59.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 51.31998553, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 51.31998553, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 51.31998553, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 51.31998553, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-UY-A9PH-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "UY", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3177, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.9, "TISSUE_SOURCE_SITE": "University of California San Francisco", "TBL_SCORE": 116.0 }, "treatments": [] }, "TCGA-CU-A3YL": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "087A7F70-2FA8-4A16-B130-4DF10A70C662", "AGE": 67, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 906.0, "DAYS_TO_BIRTH": -24524.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/24/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.78597495, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.78597495, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 12.16425026, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 12.16425026, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-CU-A3YL-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3192, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.066666667, "TISSUE_SOURCE_SITE": "UNC", "TBL_SCORE": 21.0 }, "treatments": [ { "START_DATE": 155, "STOP_DATE": 224.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 155, "STOP_DATE": 224.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-H4-A2HO": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "86D1E388-B30F-48FD-9647-3848EB6134F1", "AGE": 53, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 46.0, "DAYS_TO_BIRTH": -19630.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 69.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.512312194, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.512312194, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.512312194, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.512312194, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-H4-A2HO-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "H4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3089, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.33333333, "TISSUE_SOURCE_SITE": "Medical College of Georgia", "TBL_SCORE": 274.0 }, "treatments": [] }, "TCGA-DK-A2I2": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "234086DD-5A74-4FF1-94AB-BAD43EE69D5C", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -23116.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 75.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 7.791695434, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 7.791695434, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 5.358845383, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A2I2-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.307, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 13.56666667, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 170.0 }, "treatments": [] }, "TCGA-UY-A78P": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "B8F3D552-2D4B-4DD8-B0E8-6A38E1BAA2F3", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2380.0, "DAYS_TO_BIRTH": -28719.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 78.24571786, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 78.24571786, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 78.24571786, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 78.24571786, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-UY-A78P-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "UY", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3317, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.533333333, "TISSUE_SOURCE_SITE": "University of California San Francisco", "TBL_SCORE": 85.0 }, "treatments": [] }, "TCGA-ZF-A9R7": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "CE4E4549-BEFC-447F-9B79-ED46E302E6D7", "AGE": 76, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 665.0, "DAYS_TO_BIRTH": -28063.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 66.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.86277411, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.86277411, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.86277411, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.86277411, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-A9R7-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3149, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 21.16666667, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 115.0 }, "treatments": [] }, "TCGA-DK-AA6T": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "F9B55748-605A-4313-BB19-DCF5476590C2", "AGE": 63, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 572.0, "DAYS_TO_BIRTH": -23198.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/7/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 63.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.80527337, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.80527337, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.80527337, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.80527337, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-AA6T-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3211, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.833333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 27.0 }, "treatments": [ { "START_DATE": 75, "STOP_DATE": 110.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 75, "STOP_DATE": 110.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 24, "STOP_DATE": 24.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 10.0, "RADIATION_DOSAGE": 3000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-KQ-A41P": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "D7AF7E2C-F742-46ED-814B-1967D7E8C2D2", "AGE": 76, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1094.0, "DAYS_TO_BIRTH": -27816.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/13/2015", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 64.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.96672913, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.96672913, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 5.851990663, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-KQ-A41P-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "KQ", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3389, "MSI_SENSOR_SCORE": 0.37, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.3, "TISSUE_SOURCE_SITE": "Cornell Medical College", "TBL_SCORE": 268.0 }, "treatments": [ { "START_DATE": 189, "STOP_DATE": 331.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 189, "STOP_DATE": 331.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-KQ-A41R": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "E492D5A9-7EC5-454B-AE89-077C90F67489", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1350.0, "DAYS_TO_BIRTH": -29351.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/13/2015", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 44.38307525, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 44.38307525, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 44.38307525, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 44.38307525, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-KQ-A41R-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "KQ", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3252, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 22.76666667, "TISSUE_SOURCE_SITE": "Cornell Medical College", "TBL_SCORE": 182.0 }, "treatments": [] }, "TCGA-GD-A3OQ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "2E85C30C-C4C4-4096-9EEF-4EB2C7D991A3", "AGE": 48, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 95.0, "DAYS_TO_BIRTH": -17682.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 3.123253444, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 3.123253444, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 3.123253444, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GD-A3OQ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3291, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.133333333, "TISSUE_SOURCE_SITE": "ABS - IUPUI", "TBL_SCORE": 17.0 }, "treatments": [] }, "TCGA-BT-A2LA": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "797A71EE-372D-41E5-AEEE-5AB3C4661110", "AGE": 54, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 522.0, "DAYS_TO_BIRTH": -20032.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/22/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.1", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 95.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.16145577, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.16145577, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.16145577, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.16145577, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A2LA-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.317, "MSI_SENSOR_SCORE": 0.47, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.966666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 163.0 }, "treatments": [ { "START_DATE": 96, "STOP_DATE": 180.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 96, "STOP_DATE": 180.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Etoposide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-K4-A4AB": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "8B7556ED-2DAB-4180-AF5B-0E113E26B36E", "AGE": 76, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 84.0, "DAYS_TO_BIRTH": -27922.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/28/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.761613571, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.761613571, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.761613571, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-K4-A4AB-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "K4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3107, "MSI_SENSOR_SCORE": 0.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.933333333, "TISSUE_SOURCE_SITE": "ABS - Lahey Clinic", "TBL_SCORE": 28.0 }, "treatments": [] }, "TCGA-XF-A9T3": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "5F7C3B2D-9A5B-470F-BD12-9C7787A543F0", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": 68.0, "DAYS_TO_BIRTH": -25532.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/30/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 50.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.235591939, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.235591939, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.235591939, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9T3-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3388, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.96666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 42.0 }, "treatments": [] }, "TCGA-YC-A9TC": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "6EE03F14-14AC-4CB9-BD23-B69704176301", "AGE": 71, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -26283.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/1/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M1", "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 84.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 0.657527041, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 0.657527041, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 0.657527041, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-YC-A9TC-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "YC", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3269, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.733333333, "TISSUE_SOURCE_SITE": "Spectrum Health", "TBL_SCORE": 37.0 }, "treatments": [ { "START_DATE": 5, "STOP_DATE": 10.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "radiographic progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 5.0, "RADIATION_DOSAGE": 2000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 5, "STOP_DATE": 10.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "radiographic progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 5.0, "RADIATION_DOSAGE": 2000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-G2-AA3C": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "C04CC413-95B0-4B56-AF55-9596A5EAD4A6", "AGE": 66, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -24267.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/11/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 90.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 6.93691028, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 6.93691028, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 6.93691028, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-G2-AA3C-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "G2", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3241, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.366666667, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 57.0 }, "treatments": [ { "START_DATE": 111, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 111, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DK-AA6W": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "63FA8434-4A6F-4C32-9C5D-89DCC913900B", "AGE": 78, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 263.0, "DAYS_TO_BIRTH": -28853.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/7/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 103.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 13.6436861, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 13.6436861, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 12.46013742, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-AA6W-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.33, "MSI_SENSOR_SCORE": 0.13, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.766666667, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 191.0 }, "treatments": [ { "START_DATE": 263, "STOP_DATE": 328.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 263, "STOP_DATE": 295.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-C4-A0F6": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "4ff9b4f2-6d04-4fed-8796-155902a8bf28", "AGE": 82, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 700.0, "DAYS_TO_BIRTH": -29951.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.01344643, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.01344643, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.01344643, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-C4-A0F6-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "C4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2858, "MSI_SENSOR_SCORE": 0.4, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.366666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 158.0 }, "treatments": [] }, "TCGA-FD-A6TG": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "0C890030-9BDB-4247-A3D5-A004F992F99C", "AGE": 73, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 81.0, "DAYS_TO_BIRTH": -26893.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/5/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 76.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 3.05750074, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 3.05750074, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 3.05750074, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A6TG-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3202, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 12.06666667, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 279.0 }, "treatments": [] }, "TCGA-G2-A2ES": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "72D8EAE8-9EFB-45B2-ACBD-82C6B5732E38", "AGE": 85, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 525.0, "DAYS_TO_BIRTH": -31293.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 91.9, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 33.00785745, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 33.00785745, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 29.49008778, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-G2-A2ES-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "G2", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.298, "MSI_SENSOR_SCORE": 0.13, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 13.73333333, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 115.0 }, "treatments": [] }, "TCGA-YF-AA3L": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "661967E5-94B3-4F98-9402-6AB137893C16", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 364.0, "DAYS_TO_BIRTH": -17268.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/23/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 112.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.96699214, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.96699214, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.96699214, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.96699214, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-YF-AA3L-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "YF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3276, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.4, "TISSUE_SOURCE_SITE": "University of Puerto Rico", "TBL_SCORE": 226.0 }, "treatments": [ { "START_DATE": 215, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 214, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BT-A20J": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "74b1e72d-fdd0-4d84-8858-3bb32d58ff7e", "AGE": 75, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -27646.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 19.03540783, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 19.03540783, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.350593418, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A20J-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2897, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.26666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 295.0 }, "treatments": [] }, "TCGA-FD-A43N": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "3CCCFFEA-BD7D-4548-BB38-FE5EDA630DE6", "AGE": 76, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 230.0, "DAYS_TO_BIRTH": -27833.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/28/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 107.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.98057008, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.98057008, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.98057008, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A43N-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2928, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.533333333, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 181.0 }, "treatments": [] }, "TCGA-UY-A78L": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "D46F7976-6061-4CA9-8294-6C215703662B", "AGE": 62, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1127.0, "DAYS_TO_BIRTH": -22717.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 92.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 37.05164875, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.05164875, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.67110497, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-UY-A78L-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "UY", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3174, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.266666667, "TISSUE_SOURCE_SITE": "University of California San Francisco", "TBL_SCORE": 50.0 }, "treatments": [ { "START_DATE": 152, "STOP_DATE": 232.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 152, "STOP_DATE": 232.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-XF-A9T4": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "F9A03EAA-A228-429C-99C5-8E877379DB0F", "AGE": 48, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -17728.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/1/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 80.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 16.27379426, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 16.27379426, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 5.983496071, "GENETIC_ANCESTRY_LABEL": "EUR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9T4-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3207, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 56.0 }, "treatments": [ { "START_DATE": 158, "STOP_DATE": 281.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 158, "STOP_DATE": 281.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 402, "STOP_DATE": 436.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Ifosfamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 402, "STOP_DATE": 436.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 402, "STOP_DATE": 436.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BT-A42B": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "DB84C62D-6904-4EA8-8E51-1262B8D6FF90", "AGE": 59, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 469.0, "DAYS_TO_BIRTH": -21788.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/4/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 185.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 17.55597199, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 17.55597199, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 17.55597199, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A42B-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3184, "MSI_SENSOR_SCORE": 0.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 139.0 }, "treatments": [ { "START_DATE": 121, "STOP_DATE": 190.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 121, "STOP_DATE": 190.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 121, "STOP_DATE": 190.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DK-AA75": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "CEA28EAC-4442-4436-B737-536E45B89989", "AGE": 82, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -30090.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/7/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 85.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 11.17795969, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 11.17795969, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.78344347, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-AA75-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3282, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.0, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 181.0 }, "treatments": [] }, "TCGA-E7-A4IJ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "FAF4C71C-C4F3-4513-8C44-9114A5D3729A", "AGE": 56, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 408.0, "DAYS_TO_BIRTH": -20723.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/11/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 46.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 22.15866128, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 22.15866128, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 20.38333827, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 20.38333827, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-E7-A4IJ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3251, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.16666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 254.0 }, "treatments": [] }, "TCGA-CF-A47S": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "D2DF20D4-6704-41E6-B33D-616225BD737C", "AGE": 41, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 333.0, "DAYS_TO_BIRTH": -15225.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/11/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": 63.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.94782523, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.94782523, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.94782523, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.94782523, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A47S-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.296, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 109, "STOP_DATE": 317.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bacillus Calmette-Guerin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 109, "STOP_DATE": 324.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 109, "STOP_DATE": 115.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 30.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FD-A3SR": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "72D6E9AA-4A99-4FC9-A67B-4631E95FB043", "AGE": 68, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -24979.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/16/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 103.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 19.79156393, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 19.79156393, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 12.23000296, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A3SR-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3293, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.433333333, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 221.0 }, "treatments": [ { "START_DATE": 146, "STOP_DATE": 244.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 146, "STOP_DATE": 244.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-ZF-A9R0": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "5B39A0DC-8AB2-46C6-95C7-65DF919EBC76", "AGE": 82, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 567.0, "DAYS_TO_BIRTH": -30222.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/13/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 80.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 22.35591939, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 22.35591939, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 18.37788079, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-A9R0-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.324, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.9, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 90.0 }, "treatments": [] }, "TCGA-BT-A3PK": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "73041FCF-F3B6-4851-B34D-1D62A1FCF6FE", "AGE": 80, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 63.0, "DAYS_TO_BIRTH": -29314.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/5/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 90.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 9.961534668, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 9.961534668, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 9.961534668, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A3PK-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3436, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.53333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 67.0 }, "treatments": [] }, "TCGA-E5-A4TZ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "CA6403DD-3BD5-4023-8EA1-9957EC44DBA5", "AGE": 64, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -23566.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/19/2013", "HISTORY_NEOADJUVANT_TRTYN": "Yes", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 94.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 15.3532564, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 15.3532564, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 14.30121314, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E5-A4TZ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E5", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3413, "MSI_SENSOR_SCORE": 1.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.03333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 169.0 }, "treatments": [ { "START_DATE": 351, "STOP_DATE": 421.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 351, "STOP_DATE": 421.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 435, "STOP_DATE": 448.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 10.0, "RADIATION_DOSAGE": 300.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-2F-A9KO": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "DD3A6357-9087-44B2-9956-F981E0DE6F1C", "AGE": 63, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 678.0, "DAYS_TO_BIRTH": -23323.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/19/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 65.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 24.1312424, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 24.1312424, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 21.40250518, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-2F-A9KO-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "2F", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3271, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 16.66666667, "TISSUE_SOURCE_SITE": "Erasmus MC", "TBL_SCORE": 214.0 }, "treatments": [] }, "TCGA-5N-A9KM": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "9743E684-25DD-4DD9-9B84-6AE9518D1818", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -26906.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/16/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 17.42446658, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 17.42446658, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 9.073873163, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 9.073873163, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-5N-A9KM-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "5N", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.341, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.3, "TISSUE_SOURCE_SITE": "University Hospital Erlangen", "TBL_SCORE": 87.0 }, "treatments": [] }, "TCGA-CF-A8HX": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "43F9B602-683A-4FA1-B044-8FC5794B1453", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 345.0, "DAYS_TO_BIRTH": -20259.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/30/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 56.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.34234145, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.34234145, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.34234145, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.34234145, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A8HX-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3363, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 69.0 }, "treatments": [] }, "TCGA-ZF-AA5P": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "24D56331-4BCA-4AB8-9FB7-A95A30B4C8FE", "AGE": 65, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 372.0, "DAYS_TO_BIRTH": -23971.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 84.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.23000296, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.23000296, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.23000296, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-AA5P-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3325, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 84.0 }, "treatments": [] }, "TCGA-GU-A766": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "E7680A8E-1C0E-426B-ABD8-D0D8E7D0E5AA", "AGE": 62, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 480.0, "DAYS_TO_BIRTH": -22774.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/19/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 102.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.78064898, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.78064898, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.78064898, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GU-A766-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3425, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.6, "TISSUE_SOURCE_SITE": "BLN - UT Southwestern Medical Center at Dallas", "TBL_SCORE": 81.0 }, "treatments": [] }, "TCGA-XF-A9SV": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "CDFD86DB-15E2-4D38-A717-2207E8DE2D8F", "AGE": 82, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -30265.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/4/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 74.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 12.75602459, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 12.75602459, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.791695434, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9SV-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3499, "MSI_SENSOR_SCORE": 0.13, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.066666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 119.0 }, "treatments": [ { "START_DATE": 0, "STOP_DATE": 0.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bacillus Calmette-Guerin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 174, "STOP_DATE": 208.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 174, "STOP_DATE": 208.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 258, "STOP_DATE": 342.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vorinostat", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-ZF-AA58": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "0DA6502C-058D-47F5-9996-8AA1D511D7E4", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1649.0, "DAYS_TO_BIRTH": -22549.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 71.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 54.21310451, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 54.21310451, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 54.21310451, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-AA58-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3394, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.866666667, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 156.0 }, "treatments": [ { "START_DATE": 166, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 166, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-ZF-AA4T": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "1859A4C5-78BC-4B1A-A26E-3D2B4CB221C2", "AGE": 65, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -23974.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 85.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 19.69293487, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 19.69293487, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 16.79981589, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-AA4T-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3218, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.966666667, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 389.0 }, "treatments": [] }, "TCGA-DK-A6B0": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "73BC18A4-3600-409E-A2B5-E09E2B3F040D", "AGE": 61, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2330.0, "DAYS_TO_BIRTH": -22439.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/6/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 79.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 76.60190025, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 76.60190025, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 76.60190025, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 76.60190025, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A6B0-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3166, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-DK-A3WX": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "D63C186D-ADD6-492E-8250-E83F46D39D00", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -24553.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/31/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 70.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 10.55330901, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 10.55330901, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 5.490350791, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A3WX-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3191, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 28.0 }, "treatments": [ { "START_DATE": 56, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 56, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 253, "STOP_DATE": 270.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FD-A3SS": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "7B98B829-FDC7-4719-BEE9-C83F6154019C", "AGE": 66, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 60.0, "DAYS_TO_BIRTH": -24408.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/16/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 87.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 12.85465365, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 12.85465365, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.232797449, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A3SS-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3313, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.73333333, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 44.0 }, "treatments": [ { "START_DATE": 87, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 87, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DK-A6AW": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "01C815BA-7BDA-4F7E-865C-0C5776FEBF2C", "AGE": 70, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1621.0, "DAYS_TO_BIRTH": -25644.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/6/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 95.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 53.29256666, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 53.29256666, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 53.29256666, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 53.29256666, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A6AW-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3077, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 118.6333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 17.0 }, "treatments": [] }, "TCGA-GC-A3RB": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "A0BCF1B1-4DD4-4D7F-B63E-B49296671451", "AGE": 54, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 582.0, "DAYS_TO_BIRTH": -20021.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/25/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.13403689, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.13403689, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.13403689, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.13403689, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GC-A3RB-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GC", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.323, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.133333333, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 426.0 }, "treatments": [] }, "TCGA-XF-AAMW": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "19DA59A8-B67A-438D-900A-92A71E03BEF3", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -28903.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/13/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 63.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 8.317717066, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 8.317717066, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.317717066, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-AAMW-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3357, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 261.0 }, "treatments": [] }, "TCGA-BT-A20W": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "4dc5cffe-ed8c-47ab-b5fc-f9615b5414f7", "AGE": 71, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -26078.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 8.350593418, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 8.350593418, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 8.350593418, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 8.350593418, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A20W-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2923, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.8, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 353.0 }, "treatments": [] }, "TCGA-G2-AA3F": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "9883C38F-87BF-4421-BFC0-1B1001F8159C", "AGE": 77, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 893.0, "DAYS_TO_BIRTH": -28457.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/11/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 91.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.35858237, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.35858237, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.35858237, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-G2-AA3F-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "G2", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.327, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.4, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 165.0 }, "treatments": [ { "START_DATE": 5, "STOP_DATE": 54.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 5, "STOP_DATE": 54.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vinblastine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 5, "STOP_DATE": 54.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 5, "STOP_DATE": 54.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-E7-A519": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "74216D58-9E34-4A2B-B4AF-886C4A3DC079", "AGE": 72, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 508.0, "DAYS_TO_BIRTH": -26427.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/22/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 79.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.70118684, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.70118684, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.70118684, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.70118684, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E7-A519-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3046, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.233333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-GC-A3RC": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "BD7F2C90-863E-4380-AD31-8755BCB2F975", "AGE": 59, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 484.0, "DAYS_TO_BIRTH": -21668.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/25/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 111.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.91215439, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.91215439, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.91215439, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.91215439, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GC-A3RC-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GC", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3332, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.4, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 150.0 }, "treatments": [] }, "TCGA-FD-A5BX": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "6BD85AE2-9D27-4285-A280-4469DD2A8B0A", "AGE": 82, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -30276.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/2/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 104.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 5.687608903, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 5.687608903, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 3.254758852, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A5BX-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3172, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.76666667, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 24.0 }, "treatments": [] }, "TCGA-DK-AA71": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "22DBEA93-3E1B-4E1B-BA40-55F08B99E73B", "AGE": 71, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 415.0, "DAYS_TO_BIRTH": -25950.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/7/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.6436861, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.6436861, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.6436861, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-AA71-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3431, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 20.0, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 115.0 }, "treatments": [] }, "TCGA-XF-AAN3": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "24AD2168-B25A-4DE8-A021-DFE1C74FCC6E", "AGE": 76, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2625.0, "DAYS_TO_BIRTH": -27909.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/20/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 56.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 86.30042411, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 86.30042411, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 86.30042411, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-AAN3-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.323, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.333333333, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 8.0 }, "treatments": [ { "START_DATE": 121, "STOP_DATE": 142.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 121, "STOP_DATE": 142.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-4Z-AA82": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "32E79B35-A33A-4CA0-BFB7-7EA7E4E26568", "AGE": 59, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1538.0, "DAYS_TO_BIRTH": -21893.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/21/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 61.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 51.15560377, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 51.15560377, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 37.80780485, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-4Z-AA82-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "4Z", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3367, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.166666667, "TISSUE_SOURCE_SITE": "Barretos Cancer Hospital", "TBL_SCORE": 224.0 }, "treatments": [] }, "TCGA-E7-A7DU": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "6F30B069-C8F5-424C-9FB5-F7DBA508CB8B", "AGE": 73, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 28.0, "DAYS_TO_BIRTH": -27000.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/16/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 110.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.920537857, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.920537857, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.920537857, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.920537857, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E7-A7DU-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3325, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.266666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 29.0 }, "treatments": [] }, "TCGA-DK-A2I1": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "036B9681-AB58-4734-A8FD-E0D5D078BF5A", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 546.0, "DAYS_TO_BIRTH": -26726.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 71.5, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.95048821, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.95048821, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.95048821, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.95048821, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A2I1-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2833, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 23.83333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 296.0 }, "treatments": [] }, "TCGA-E7-A8O7": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "1E15CB17-CF22-4F06-A3D9-E528E77D1876", "AGE": 52, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 466.0, "DAYS_TO_BIRTH": -19063.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/3/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 58.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.32038005, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.32038005, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.32038005, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.32038005, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-E7-A8O7-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3141, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.833333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 10.0 }, "treatments": [] }, "TCGA-DK-A1A5": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "904a8757-e0c5-41ef-b583-c8f170caaac1", "AGE": 79, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -29111.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 2.136962883, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.136962883, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.136962883, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.136962883, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A1A5-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3039, "MSI_SENSOR_SCORE": 1.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.933333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 154.0 }, "treatments": [] }, "TCGA-4Z-AA7N": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "7934BD8C-0822-44A3-88A4-A3135A448F2B", "AGE": 65, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 655.0, "DAYS_TO_BIRTH": -24090.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/21/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 90.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 44.94197324, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 44.94197324, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 44.94197324, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 44.94197324, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-4Z-AA7N-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "4Z", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.329, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.4, "TISSUE_SOURCE_SITE": "Barretos Cancer Hospital", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-GC-A3BM": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "7840AEA9-40C4-473E-BE33-8FA0B9F332C9", "AGE": 70, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 88.0, "DAYS_TO_BIRTH": -25609.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/25/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.1", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 86.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 21.40250518, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 21.40250518, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 21.40250518, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GC-A3BM-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GC", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 29.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3198, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.766666667, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 59.0 }, "treatments": [] }, "TCGA-CF-A1HS": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "a73c0842-39c5-4c2c-aa6a-f31341a4f36e", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 382.0, "DAYS_TO_BIRTH": -27565.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/17/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8070/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 52.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.55876648, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.55876648, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 4.372554821, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 4.372554821, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A1HS-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2912, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.033333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 214.0 }, "treatments": [ { "START_DATE": 143, "STOP_DATE": 196.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 34.0, "RADIATION_DOSAGE": 68.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DK-AA6X": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "071B350D-8745-4795-8194-A8C6491F0931", "AGE": 63, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 467.0, "DAYS_TO_BIRTH": -23208.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/7/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.3532564, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.3532564, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.3532564, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-AA6X-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3316, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.666666667, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 30.0 }, "treatments": [] }, "TCGA-DK-A1A6": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "9c274536-3ca1-4f0e-93a8-1688074d862f", "AGE": 53, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2020.0, "DAYS_TO_BIRTH": -19554.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "4/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 97.91, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 66.41023112, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 66.41023112, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 66.41023112, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A1A6-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3055, "MSI_SENSOR_SCORE": 0.56, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 203.0 }, "treatments": [] }, "TCGA-SY-A9G0": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "423B7FC5-3970-4C96-990D-96AD0842F1EB", "AGE": 82, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 378.0, "DAYS_TO_BIRTH": -30205.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/7/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 82.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 33.13936286, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.13936286, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.13936286, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-SY-A9G0-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "SY", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 31.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3251, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "Mayo Clinic Arizona", "TBL_SCORE": 23.0 }, "treatments": [] }, "TCGA-G2-A3IE": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "C65BA2B8-E867-42E8-BBD0-C2CDF5130CFB", "AGE": 51, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -18983.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/22/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 98.1, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 20.12032745, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 20.12032745, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 20.12032745, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-G2-A3IE-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "G2", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3344, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.23333333, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 83.0 }, "treatments": [ { "START_DATE": 29, "STOP_DATE": 68.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Ifosfamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 29, "STOP_DATE": 68.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 29, "STOP_DATE": 68.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 81, "STOP_DATE": 100.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 81, "STOP_DATE": 100.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 81, "STOP_DATE": 100.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vinblastine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 81, "STOP_DATE": 100.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BL-A5ZZ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "C1AFC5EB-8C1D-4B6C-8453-48728FC023BA", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 377.0, "DAYS_TO_BIRTH": -29247.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/7/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 71.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.39438472, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.39438472, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 7.956077194, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.956077194, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BL-A5ZZ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BL", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3018, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.733333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 31.0 }, "treatments": [] }, "TCGA-ZF-A9R9": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "EBAD8BC9-F196-4F53-BFEA-DE38488EB4E1", "AGE": 58, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -21491.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/14/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 28.40516816, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 28.40516816, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 20.67922543, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-A9R9-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3215, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.1, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 102.0 }, "treatments": [] }, "TCGA-G2-A2EK": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "5DA1CB68-C438-4DDC-999F-90AED0C4BD7A", "AGE": 57, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 485.0, "DAYS_TO_BIRTH": -20995.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 159.3, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.94503074, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.94503074, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 15.94503074, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-G2-A2EK-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "G2", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2933, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.166666667, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 100.0 }, "treatments": [ { "START_DATE": 16, "STOP_DATE": 51.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 16, "STOP_DATE": 51.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 16, "STOP_DATE": 51.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vinblastine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 16, "STOP_DATE": 51.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-E7-A6ME": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "9F00847C-BD1F-4CD0-99F9-D51D638C0795", "AGE": 75, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 731.0, "DAYS_TO_BIRTH": -27670.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/24/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 59.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.03261334, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.03261334, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.03261334, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.03261334, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-E7-A6ME-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3346, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.1, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 114.0 }, "treatments": [] }, "TCGA-ZF-A9RM": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "7D71945A-B81A-405C-BB17-CEC9B1D7592C", "AGE": 70, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1455.0, "DAYS_TO_BIRTH": -25642.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T0", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 87.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 47.83509222, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 47.83509222, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 47.83509222, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 47.83509222, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-A9RM-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3234, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.8, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 182.0 }, "treatments": [] }, "TCGA-G2-A2EF": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "2A142731-119C-495D-AD30-EB0B48BACB46", "AGE": 50, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1884.0, "DAYS_TO_BIRTH": -18467.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 73.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 61.93904724, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 61.93904724, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 61.93904724, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-G2-A2EF-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "G2", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3043, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.9, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 304.0 }, "treatments": [ { "START_DATE": 58, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 58, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vinblastine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 58, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 58, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FD-A5BZ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "AC187CD1-A5EF-47DA-88B2-1D4DF27E0E76", "AGE": 77, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -28451.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/2/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 61.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 27.45175395, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 27.45175395, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 17.52309564, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A5BZ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3006, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.633333333, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 156.0 }, "treatments": [] }, "TCGA-E7-A85H": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "C8ADCE3D-4914-4851-9952-846B0C9C32DE", "AGE": 64, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 394.0, "DAYS_TO_BIRTH": -23497.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/3/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 48.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.9532827, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.9532827, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.9532827, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.9532827, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-E7-A85H-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3438, "MSI_SENSOR_SCORE": 0.32, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 12.9, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 687.0 }, "treatments": [] }, "TCGA-ZF-AA56": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "EB30AE33-2076-475D-AAC9-804A8F1119A0", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -28937.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 63.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 8.514975178, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 8.514975178, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.153335306, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-AA56-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3257, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.433333333, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 114.0 }, "treatments": [] }, "TCGA-DK-AA6Q": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "60419F8C-92C2-4E8F-B2FA-A767D30C9D59", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -22314.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/7/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 64.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 13.57793339, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 13.57793339, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 9.369760331, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-DK-AA6Q-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3192, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.8, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 61.0 }, "treatments": [] }, "TCGA-K4-A5RH": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "EECA58FE-B5CB-4D13-A93F-A5A2CA00B6E2", "AGE": 69, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 276.0, "DAYS_TO_BIRTH": -25305.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/20/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.073873163, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.073873163, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 6.443765, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-K4-A5RH-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "K4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3108, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.33333333, "TISSUE_SOURCE_SITE": "ABS - Lahey Clinic", "TBL_SCORE": 162.0 }, "treatments": [ { "START_DATE": 220, "STOP_DATE": 248.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 14.0, "RADIATION_DOSAGE": 3500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DK-A1AA": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "56d8a1b8-1268-4362-a7f1-77b76fbf1b59", "AGE": 57, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 578.0, "DAYS_TO_BIRTH": -21093.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 104.3, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.00253148, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.00253148, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.00253148, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.00253148, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A1AA-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2842, "MSI_SENSOR_SCORE": 1.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.533333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 32.0 }, "treatments": [ { "START_DATE": 92, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": null, "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "adjuvant (1st line)", "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-XF-A8HH": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "02964D82-CC94-4286-A66F-03567101950C", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -22393.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/13/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 72.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 1.873952066, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 1.873952066, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 1.873952066, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A8HH-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3185, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.8, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 67.0 }, "treatments": [] }, "TCGA-FD-A43S": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "77236911-D9E0-4B85-829A-A98F1E4B92D2", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 455.0, "DAYS_TO_BIRTH": -25993.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/29/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 61.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.95874018, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.95874018, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.95874018, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.95874018, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A43S-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3095, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": null, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 111, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 111, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FD-A3B6": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "36054200-3FA4-4541-A25C-47282E4EF88D", "AGE": 75, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 209.0, "DAYS_TO_BIRTH": -27541.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 72.57, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 33.0407338, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.0407338, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 33.0407338, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.0407338, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A3B6-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.342, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.566666667, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 225.0 }, "treatments": [] }, "TCGA-CU-A3QU": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "AE6D853B-A7F0-4465-B7BF-5A45006AB3B3", "AGE": 58, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 158.0, "DAYS_TO_BIRTH": -21233.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/24/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 87.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 5.194463622, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 5.194463622, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 5.194463622, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-CU-A3QU-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3389, "MSI_SENSOR_SCORE": 0.47, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.866666667, "TISSUE_SOURCE_SITE": "UNC", "TBL_SCORE": 100.0 }, "treatments": [] }, "TCGA-GV-A3QH": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "33BC6A7C-9844-41E3-96B3-1E34BB3FEDD5", "AGE": 67, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 237.0, "DAYS_TO_BIRTH": -24681.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/18/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 91.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 8.482098826, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 8.482098826, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 4.109544005, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GV-A3QH-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GV", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 26.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3291, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.233333333, "TISSUE_SOURCE_SITE": "BLN - Cleveland Clinic", "TBL_SCORE": 191.0 }, "treatments": [ { "START_DATE": 135, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 135, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BT-A0S7": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "68bc786e-07c7-4964-bc88-5e2a8633626a", "AGE": 75, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -27533.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 104.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 6.575270408, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 6.575270408, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 6.575270408, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A0S7-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2768, "MSI_SENSOR_SCORE": 0.13, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 76.0 }, "treatments": [] }, "TCGA-FD-A3SO": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "94809FBF-4895-42C0-A7C6-F39EE1A41F1A", "AGE": 68, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -25147.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/16/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 88.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 5.523227143, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 5.523227143, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 4.701318342, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A3SO-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.331, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.76666667, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 25.0 }, "treatments": [ { "START_DATE": 65, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 66, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-XF-AAMF": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "93FBE302-A2E0-4CF4-A638-312786F547C2", "AGE": 68, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -25023.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/12/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 10.81631982, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 10.81631982, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 5.16158727, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-AAMF-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3395, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.366666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 63.0 }, "treatments": [ { "START_DATE": 161, "STOP_DATE": 274.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 161, "STOP_DATE": 274.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-KQ-A41S": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "CC8602BB-78E2-4732-9784-83C3388B999E", "AGE": 87, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 35.0, "DAYS_TO_BIRTH": -32041.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "7/13/2015", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.150672321, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.150672321, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.150672321, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.150672321, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-KQ-A41S-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "KQ", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 34.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3092, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.933333333, "TISSUE_SOURCE_SITE": "Cornell Medical College", "TBL_SCORE": 22.0 }, "treatments": [] }, "TCGA-XF-AAN8": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "AA14E232-C6C6-4075-9D15-E1857373D233", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -27309.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 66.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 3.879409541, "DSS_STATUS": null, "DSS_MONTHS": 3.879409541, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 3.879409541, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-AAN8-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3303, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.033333333, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 12.0 }, "treatments": [] }, "TCGA-XF-A8HE": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "841B4582-A268-4A55-A9A2-47C7E5C3B69F", "AGE": 47, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3817.0, "DAYS_TO_BIRTH": -17212.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/3/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 80.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 125.4890357, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 125.4890357, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 125.4890357, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 125.4890357, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A8HE-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3143, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 12.73333333, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 23.0 }, "treatments": [] }, "TCGA-R3-A69X": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "692A6CED-0246-4E5E-AD2F-20450073F335", "AGE": 70, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 433.0, "DAYS_TO_BIRTH": -25576.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/17/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 54.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.23546043, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.23546043, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.23546043, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.23546043, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-R3-A69X-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "R3", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 32.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3088, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.666666667, "TISSUE_SOURCE_SITE": "CHI-Penrose Colorado", "TBL_SCORE": 30.0 }, "treatments": [] }, "TCGA-GU-A42P": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "FF5B9238-38A7-42B4-9D44-3B8EC9913F6D", "AGE": 72, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 195.0, "DAYS_TO_BIRTH": -26546.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/30/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 80.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 10.91494888, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.91494888, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.91494888, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GU-A42P-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3554, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.266666667, "TISSUE_SOURCE_SITE": "BLN - UT Southwestern Medical Center at Dallas", "TBL_SCORE": 98.0 }, "treatments": [] }, "TCGA-FD-A3NA": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "14917461-DAE4-44CB-909D-42AC45AEF450", "AGE": 60, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1845.0, "DAYS_TO_BIRTH": -21936.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/21/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 80.74, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 60.65686951, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 60.65686951, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 60.65686951, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 43.98855903, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A3NA-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3275, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.6, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 211.0 }, "treatments": [] }, "TCGA-FD-A3SN": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "0FB043D3-D86B-4CD8-8C01-9E2B3E965BB0", "AGE": 79, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 887.0, "DAYS_TO_BIRTH": -29169.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/16/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 70.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.16132426, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.16132426, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 3.616398724, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-FD-A3SN-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3376, "MSI_SENSOR_SCORE": 0.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.3, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 46.0 }, "treatments": [ { "START_DATE": 117, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 117, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-CF-A3MH": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "B8A8D2FC-421B-4393-8D5A-946CF72CB496", "AGE": 75, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 398.0, "DAYS_TO_BIRTH": -27458.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/6/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": 59.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.08478811, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.08478811, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.08478811, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.08478811, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A3MH-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3457, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 38.0 }, "treatments": [ { "START_DATE": 119, "STOP_DATE": 146.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 50.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FD-A6TA": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "FCDA9873-3A93-40B2-913D-4DF1E6A27EFB", "AGE": 58, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1912.0, "DAYS_TO_BIRTH": -21196.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/5/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 86.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 62.8595851, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 62.8595851, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 62.8595851, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A6TA-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3124, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.4, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 255.0 }, "treatments": [ { "START_DATE": 55, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 55, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vinblastine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 55, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 55, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-GC-A4ZW": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "A9E17A7D-7FF4-44E3-B8C9-B0D2F46B6CD5", "AGE": 71, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 15.0, "DAYS_TO_BIRTH": -25964.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/15/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 89.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.493145281, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.493145281, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.493145281, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GC-A4ZW-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GC", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2993, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 20.7, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 320.0 }, "treatments": [] }, "TCGA-ZF-A9R3": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "AB77B411-4DF2-4E3A-BFAD-946E8BB1FA70", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 734.0, "DAYS_TO_BIRTH": -19384.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 110.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 31.19965809, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 31.19965809, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 30.14761482, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 30.14761482, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-A9R3-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3303, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.666666667, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 36.0 }, "treatments": [] }, "TCGA-CF-A9FF": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "736E8CDF-E2D7-4141-86A9-45C34178A1C8", "AGE": 52, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 361.0, "DAYS_TO_BIRTH": -19195.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/30/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 54.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.86836309, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.86836309, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.86836309, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.86836309, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A9FF-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3177, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.4, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 29.0 }, "treatments": [] }, "TCGA-XF-A9SL": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "51FDB034-5D05-427B-B6B8-B6EECD65D976", "AGE": 69, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -25460.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/2/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 89.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 66.41023112, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 66.41023112, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 66.41023112, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9SL-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3304, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.966666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-K4-A3WV": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "D53EADE8-A845-4252-AECE-92F3573486A7", "AGE": 77, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 646.0, "DAYS_TO_BIRTH": -28444.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/6/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.23812342, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.23812342, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.23812342, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-K4-A3WV-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "K4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3383, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.833333333, "TISSUE_SOURCE_SITE": "ABS - Lahey Clinic", "TBL_SCORE": 398.0 }, "treatments": [] }, "TCGA-GC-A6I1": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "54C04BCC-EBD5-461E-BBD5-B4D791B00C95", "AGE": 90, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 81.0, "DAYS_TO_BIRTH": -32873.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/19/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 61.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 8.942367755, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 8.942367755, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 8.942367755, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 8.942367755, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GC-A6I1-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GC", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3267, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.066666667, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 104.0 }, "treatments": [] }, "TCGA-ZF-A9RN": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "73DB40CE-2BA7-4A56-AEF2-B78D2C744BE1", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -24795.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 91.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 20.21895651, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 20.21895651, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 16.96419765, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-A9RN-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3604, "MSI_SENSOR_SCORE": 0.51, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.566666667, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 323.0 }, "treatments": [] }, "TCGA-DK-A3IU": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "F093F043-EFD4-4CBA-A87F-8CBB5C1ACD9E", "AGE": 58, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 609.0, "DAYS_TO_BIRTH": -21369.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/10/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 96.5, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 23.21070454, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 23.21070454, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 15.18887464, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 15.18887464, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A3IU-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3433, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.86666667, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 45.0 }, "treatments": [ { "START_DATE": 521, "STOP_DATE": 578.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 521, "STOP_DATE": 578.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-UY-A9PF": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "3BD918A8-3B92-4042-B4A1-F9DFCD6FE405", "AGE": 77, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 117.0, "DAYS_TO_BIRTH": -28470.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/1/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 109.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 3.846533189, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 3.846533189, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 3.846533189, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-UY-A9PF-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "UY", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3126, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 13.93333333, "TISSUE_SOURCE_SITE": "University of California San Francisco", "TBL_SCORE": 64.0 }, "treatments": [] }, "TCGA-FD-A43P": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "41E8C196-EF93-47C6-AD06-0031F23D4347", "AGE": 74, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 832.0, "DAYS_TO_BIRTH": -27201.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/28/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.1", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 150.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.3531249, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.3531249, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 27.3531249, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.3531249, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-FD-A43P-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3277, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 12.46666667, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 233.0 }, "treatments": [] }, "TCGA-ZF-A9R5": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "AAA55DE1-8F53-4B56-BA0A-67CFF909CF81", "AGE": 59, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1090.0, "DAYS_TO_BIRTH": -21811.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/13/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 67.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.83522372, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.83522372, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 35.83522372, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 35.83522372, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-A9R5-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3446, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.2, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-GD-A2C5": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "5D54C742-5A8E-4C40-8D62-95E75E210AB8", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 812.0, "DAYS_TO_BIRTH": -19498.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/20/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 54.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.69559786, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 26.69559786, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.035539337, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GD-A2C5-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2946, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 13.33333333, "TISSUE_SOURCE_SITE": "ABS - IUPUI", "TBL_SCORE": 178.0 }, "treatments": [ { "START_DATE": 111, "STOP_DATE": 325.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": null, "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 327, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 327, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 327, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Not Specified", "TREATMENT_SUBTYPE": null, "AGENT": "Fosaprepitant", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 237, "STOP_DATE": 310.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-CU-A5W6": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "7A7FCDD3-CCE9-47CF-A26F-CC6FF34ECD9A", "AGE": 70, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -25706.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/20/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 81.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 1.841075714, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.841075714, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.841075714, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.841075714, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-CU-A5W6-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CU", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3127, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.666666667, "TISSUE_SOURCE_SITE": "UNC", "TBL_SCORE": 127.0 }, "treatments": [] }, "TCGA-CF-A47Y": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "9BCFF619-F75A-4AA4-9E09-2E9AA7B59225", "AGE": 55, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 373.0, "DAYS_TO_BIRTH": -20432.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/11/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.26287931, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.26287931, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.26287931, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.26287931, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A47Y-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3205, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-DK-A3IT": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "58520C66-7688-435A-B09F-653B18768C41", "AGE": 62, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 648.0, "DAYS_TO_BIRTH": -22786.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/13/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 110.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.30387612, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.30387612, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.30387612, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.30387612, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A3IT-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3182, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 13.3, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 173.0 }, "treatments": [] }, "TCGA-DK-A1A3": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "c5b20ccc-523d-491c-8536-008e05c57212", "AGE": 60, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 77.0, "DAYS_TO_BIRTH": -22235.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/6/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 76.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 21.86277411, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 21.86277411, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 21.86277411, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A1A3-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2939, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 18.9, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 163.0 }, "treatments": [] }, "TCGA-UY-A9PD": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "9EF9E328-AC74-4C8A-9990-347B87CF7764", "AGE": 80, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 542.0, "DAYS_TO_BIRTH": -29565.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/1/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.81898281, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.81898281, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.81898281, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.81898281, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-UY-A9PD-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "UY", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3335, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.766666667, "TISSUE_SOURCE_SITE": "University of California San Francisco", "TBL_SCORE": 323.0 }, "treatments": [] }, "TCGA-XF-A9T5": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "F9A7AB94-70DF-4194-8102-66021D01DADD", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2027.0, "DAYS_TO_BIRTH": -28578.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/5/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 75.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 66.64036559, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 66.64036559, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 21.82989776, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9T5-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3398, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 21.06666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 145.0 }, "treatments": [ { "START_DATE": 687, "STOP_DATE": 757.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 687, "STOP_DATE": 757.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 880, "STOP_DATE": 911.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 45.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 938, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DK-A1AC": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "36c14e9d-1863-4c55-bbbb-f8c9dd418932", "AGE": 72, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3981.0, "DAYS_TO_BIRTH": -26307.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 76.5, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 130.8807575, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 130.8807575, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 130.8807575, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 130.8807575, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A1AC-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3059, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 43.23333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 223.0 }, "treatments": [ { "START_DATE": 168, "STOP_DATE": 242.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": 4.0, "PRESCRIBED_DOSE": 1000.0, "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "adjuvant (1st line)", "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 129.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 178, "STOP_DATE": 242.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FJ-A3Z9": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "72FF655F-BB08-40ED-B4C3-E9497D4DA108", "AGE": 72, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 217.0, "DAYS_TO_BIRTH": -26515.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/5/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "TX", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 105.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 12.65739554, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.65739554, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.65739554, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.65739554, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FJ-A3Z9-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FJ", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2779, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.233333333, "TISSUE_SOURCE_SITE": "BLN - Baylor", "TBL_SCORE": 12.0 }, "treatments": [ { "START_DATE": 32, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 46, "STOP_DATE": 89.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-ZF-A9RF": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "FA05F7F6-50E9-4878-A834-F655C0877394", "AGE": 74, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1949.0, "DAYS_TO_BIRTH": -27281.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/11/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 64.07601013, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 64.07601013, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 51.45149094, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 51.45149094, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-A9RF-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3261, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.7, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 248.0 }, "treatments": [] }, "TCGA-XF-AAN7": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "9D7FBDEB-EA3D-4E07-8527-23C5997D77CF", "AGE": 60, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -21951.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 89.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 18.5751389, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 18.5751389, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.55330901, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-AAN7-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3503, "MSI_SENSOR_SCORE": 0.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.366666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 167.0 }, "treatments": [ { "START_DATE": 162, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 162, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 351, "STOP_DATE": 374.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Ifosfamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 0, "STOP_DATE": 9.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 0, "STOP_DATE": 9.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 399, "STOP_DATE": 442.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel + Vandetanib", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "blinded: zactima or placebo. zactima is a kinase inhibitor", "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DK-A1AF": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "f3104468-bf17-434b-8a7e-bc3b253121ea", "AGE": 84, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 536.0, "DAYS_TO_BIRTH": -30914.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 65.3, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.62172469, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.62172469, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 9.304007627, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A1AF-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2754, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.4, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 17.0 }, "treatments": [ { "START_DATE": 289, "STOP_DATE": 435.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": 800.0, "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1st line", "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1200.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-UY-A78O": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "4319AA02-6D8B-4CB8-B4E4-C4EED1CB2AC7", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2312.0, "DAYS_TO_BIRTH": -27234.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 120.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 76.01012592, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 76.01012592, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 76.01012592, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 76.01012592, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-UY-A78O-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "UY", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3287, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.866666667, "TISSUE_SOURCE_SITE": "University of California San Francisco", "TBL_SCORE": 234.0 }, "treatments": [] }, "TCGA-K4-A6MB": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "661D7B4A-A2B2-4251-B464-292421665948", "AGE": 64, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 469.0, "DAYS_TO_BIRTH": -23664.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/23/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 88.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.41900911, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.41900911, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.41900911, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-K4-A6MB-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "K4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.336, "MSI_SENSOR_SCORE": 0.3, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.06666667, "TISSUE_SOURCE_SITE": "ABS - Lahey Clinic", "TBL_SCORE": 319.0 }, "treatments": [] }, "TCGA-2F-A9KT": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "BC6C516B-591E-4950-B6B0-DECAFA666F4E", "AGE": 83, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3314.0, "DAYS_TO_BIRTH": -30520.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/19/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 80.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 108.9522307, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 108.9522307, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 108.9522307, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 108.9522307, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-2F-A9KT-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "2F", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3309, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.3, "TISSUE_SOURCE_SITE": "Erasmus MC", "TBL_SCORE": 167.0 }, "treatments": [] }, "TCGA-FD-A5BV": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "4FA31971-15E2-4C9B-B49A-B3B7096262E4", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -17501.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/1/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.0", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 47.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 5.358845383, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 5.358845383, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 4.405431173, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-FD-A5BV-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3158, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.7, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 116.0 }, "treatments": [] }, "TCGA-ZF-AA54": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "BCA645AE-A0C9-4005-B672-85D8920B6AFB", "AGE": 71, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -26128.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 81.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 19.3970477, "DSS_STATUS": null, "DSS_MONTHS": 19.3970477, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.3970477, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-AA54-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3286, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.9, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 87.0 }, "treatments": [] }, "TCGA-FJ-A3Z7": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "6B2D63F2-F390-4601-9640-F769F6E91BF4", "AGE": 76, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 945.0, "DAYS_TO_BIRTH": -28052.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/27/2012", "HISTORY_NEOADJUVANT_TRTYN": "Yes", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 84.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 31.06815268, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 31.06815268, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 31.06815268, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FJ-A3Z7-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FJ", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3483, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.933333333, "TISSUE_SOURCE_SITE": "BLN - Baylor", "TBL_SCORE": 313.0 }, "treatments": [ { "START_DATE": 70, "STOP_DATE": 70.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 70, "STOP_DATE": 70.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-GD-A76B": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "6C1FFAF7-FDAE-4AB0-8DD1-6738937357BA", "AGE": 86, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 224.0, "DAYS_TO_BIRTH": -31571.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/23/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 71.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 7.364302857, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.364302857, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 7.364302857, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 7.364302857, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GD-A76B-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.329, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.033333333, "TISSUE_SOURCE_SITE": "ABS - IUPUI", "TBL_SCORE": 35.0 }, "treatments": [] }, "TCGA-LC-A66R": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "39FDC742-8BDB-4E77-B20B-0F967A75E659", "AGE": 78, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 466.0, "DAYS_TO_BIRTH": -28793.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/27/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.32038005, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.32038005, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.32038005, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-LC-A66R-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LC", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3111, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.233333333, "TISSUE_SOURCE_SITE": "Hartford Hospital", "TBL_SCORE": 175.0 }, "treatments": [] }, "TCGA-GV-A3QI": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "06F936E9-5A90-40D3-B91A-713F2B4E6E11", "AGE": 47, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1110.0, "DAYS_TO_BIRTH": -17383.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/18/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 77.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.49275076, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.49275076, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 25.24903837, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 25.24903837, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GV-A3QI-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GV", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2822, "MSI_SENSOR_SCORE": 0.27, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.0, "TISSUE_SOURCE_SITE": "BLN - Cleveland Clinic", "TBL_SCORE": 338.0 }, "treatments": [ { "START_DATE": 771, "STOP_DATE": 895.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DK-A6B5": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "D5E8D936-40AE-4FD3-B40E-CAC54763D71F", "AGE": 45, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1542.0, "DAYS_TO_BIRTH": -16453.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/6/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 95.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 50.69533485, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.69533485, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 50.69533485, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A6B5-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3449, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.9, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 188.0 }, "treatments": [ { "START_DATE": 248, "STOP_DATE": 348.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 248, "STOP_DATE": 348.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 248, "STOP_DATE": 348.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-UY-A9PE": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "FED69898-A229-4B81-BBD9-CDCB164DAE7B", "AGE": 86, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 189.0, "DAYS_TO_BIRTH": -31755.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/1/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 84.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 6.213630536, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 6.213630536, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 15.55051452, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-UY-A9PE-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "UY", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3299, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.733333333, "TISSUE_SOURCE_SITE": "University of California San Francisco", "TBL_SCORE": 266.0 }, "treatments": [] }, "TCGA-DK-AA6M": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "D8B07FDD-5580-4BCC-9619-B5E0C9F0AA3D", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1582.0, "DAYS_TO_BIRTH": -23574.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/7/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 75.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 52.01038893, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 52.01038893, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 52.01038893, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-AA6M-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3293, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 63.0 }, "treatments": [ { "START_DATE": 735, "STOP_DATE": 820.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Not Specified", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 735, "STOP_DATE": 820.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-G2-A2EL": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "30C7445E-D0C4-4A0F-96A4-27E4259EE10B", "AGE": 77, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -28370.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 89.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 26.92573232, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 26.92573232, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 3.452016964, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-G2-A2EL-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "G2", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3067, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.0, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 69.0 }, "treatments": [ { "START_DATE": 84, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Etoposide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 84, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 376, "STOP_DATE": 397.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 10.0, "RADIATION_DOSAGE": 30.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-C4-A0F7": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "ca554128-da9d-4f37-9560-ca083509e01d", "AGE": 77, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -28428.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": 70.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 2.038333827, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 2.038333827, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 2.038333827, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-C4-A0F7-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "C4", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2902, "MSI_SENSOR_SCORE": 1.39, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.166666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 1484.0 }, "treatments": [] }, "TCGA-GD-A3OS": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "2A41B7D4-132F-4FB6-87B5-487C445379C7", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 638.0, "DAYS_TO_BIRTH": -19776.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/5/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 78.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.9751126, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.9751126, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.331426505, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GD-A3OS-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3603, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.833333333, "TISSUE_SOURCE_SITE": "ABS - IUPUI", "TBL_SCORE": 176.0 }, "treatments": [ { "START_DATE": 58, "STOP_DATE": 156.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 58, "STOP_DATE": 156.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 499, "STOP_DATE": 549.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FD-A3SJ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "6D8D8169-0C1A-4CDB-BE6F-9761C981A369", "AGE": 59, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -21615.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/11/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 79.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 24.29562416, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 24.29562416, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 9.238254923, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A3SJ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3309, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.333333333, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 432.0 }, "treatments": [ { "START_DATE": 401, "STOP_DATE": 436.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 315, "STOP_DATE": 436.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 274, "STOP_DATE": 275.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vinblastine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 274, "STOP_DATE": 275.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 274, "STOP_DATE": 380.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 274, "STOP_DATE": 275.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-G2-A2EC": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "28E25FFB-8B0C-4839-A735-ED7B78E3213A", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "2ND", "DAYS_LAST_FOLLOWUP": 679.0, "DAYS_TO_BIRTH": -21215.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 70.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 22.88194102, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 22.88194102, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 22.32304304, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-G2-A2EC-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "G2", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3259, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.533333333, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 35.0 }, "treatments": [ { "START_DATE": 24, "STOP_DATE": 75.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 24, "STOP_DATE": 75.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 24, "STOP_DATE": 75.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 24, "STOP_DATE": 75.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vinblastine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 24, "STOP_DATE": 75.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DK-A3IQ": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "E44F60EC-66C4-45A2-A003-0A1FAF1D6E03", "AGE": 74, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 319.0, "DAYS_TO_BIRTH": -27194.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 75.4, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 17.72035375, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 17.72035375, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 8.21908801, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.21908801, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A3IQ-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3002, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.633333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 157.0 }, "treatments": [ { "START_DATE": 277, "STOP_DATE": 319.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 277, "STOP_DATE": 417.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-XF-A8HD": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "DFC67E7B-3986-4129-AE02-4D8F57E776E3", "AGE": 77, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2964.0, "DAYS_TO_BIRTH": -28305.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/4/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 77.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 97.44550745, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 97.44550745, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 97.44550745, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 97.44550745, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-XF-A8HD-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3243, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.33333333, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 114.0 }, "treatments": [] }, "TCGA-ZF-A9RC": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "4ED34DB5-DDB5-4EFD-A49B-84BF26789AEE", "AGE": 77, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2868.0, "DAYS_TO_BIRTH": -28275.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 99.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 94.28937765, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 94.28937765, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 94.28937765, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 94.28937765, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-A9RC-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3184, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 28.26666667, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 122.0 }, "treatments": [] }, "TCGA-5N-A9KI": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "4FECE3D0-649C-4771-B9C4-A3397CEA0FEB", "AGE": 76, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -27777.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/16/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 61.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 2.498602755, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.498602755, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.498602755, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.498602755, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-5N-A9KI-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "5N", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3453, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.1, "TISSUE_SOURCE_SITE": "University Hospital Erlangen", "TBL_SCORE": 75.0 }, "treatments": [] }, "TCGA-BT-A42C": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "B9808EF9-E917-45F9-9E0F-B86F7834B5FF", "AGE": 64, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 873.0, "DAYS_TO_BIRTH": -23584.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/10/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 59.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 28.70105533, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.70105533, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 28.70105533, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 28.70105533, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A42C-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3324, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.46666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 133.0 }, "treatments": [] }, "TCGA-CF-A8HY": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "6A3E87D7-E360-44C5-9764-4B630DF383E6", "AGE": 59, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 345.0, "DAYS_TO_BIRTH": -21636.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/30/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 66.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.34234145, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.34234145, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.34234145, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.34234145, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A8HY-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3352, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.966666667, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 93.0 }, "treatments": [] }, "TCGA-GC-A3I6": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "74CBB078-9AAE-422A-A7AF-DD29EBCA949E", "AGE": 45, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 68.0, "DAYS_TO_BIRTH": -16504.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/17/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 81.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 20.71210179, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 20.71210179, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 17.95048821, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GC-A3I6-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GC", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3448, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.733333333, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 25.0 }, "treatments": [] }, "TCGA-XF-AAML": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "329D372C-C44E-4595-B8AC-474C5A1321A5", "AGE": 75, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -27422.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/12/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 129.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 7.627313673, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.627313673, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 7.627313673, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 7.627313673, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-AAML-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.332, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 15.0, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 126.0 }, "treatments": [] }, "TCGA-DK-A3WW": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "2AB0FB7B-AD2A-403D-9411-712974CCD878", "AGE": 57, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 633.0, "DAYS_TO_BIRTH": -20909.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/31/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 85.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.81073084, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.81073084, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.81073084, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.81073084, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DK-A3WW-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "DK", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3282, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 36.13333333, "TISSUE_SOURCE_SITE": "Memorial Sloan Kettering", "TBL_SCORE": 29.0 }, "treatments": [ { "START_DATE": 127, "STOP_DATE": 177.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 127, "STOP_DATE": 177.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 127, "STOP_DATE": 177.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-CF-A5UA": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "B52C870C-BFB8-4E68-86C0-64D57E5C9AE3", "AGE": 67, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 365.0, "DAYS_TO_BIRTH": -24625.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/3/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 52.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.9998685, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.9998685, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.9998685, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.9998685, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A5UA-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3096, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.233333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 79.0 }, "treatments": [] }, "TCGA-FD-A3B8": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "537CA5D1-5B26-496F-B7B4-05FEA7B46353", "AGE": 56, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 384.0, "DAYS_TO_BIRTH": -20555.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 92.5, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.62451918, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.62451918, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.62451918, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.62451918, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-FD-A3B8-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3357, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.266666667, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 11.0 }, "treatments": [] }, "TCGA-FD-A6TD": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "C80E71B3-7C6C-4E16-8446-6DFDA780BC18", "AGE": 77, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 204.0, "DAYS_TO_BIRTH": -28328.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/5/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.3", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 148.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 12.69027189, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.69027189, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.69027189, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.69027189, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A6TD-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3279, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.033333333, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 139.0 }, "treatments": [] }, "TCGA-LT-A5Z6": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "EC7FC492-53CC-4B71-A66A-1CEF1ADEBA33", "AGE": 56, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 474.0, "DAYS_TO_BIRTH": -20746.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/3/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 86.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.58339087, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.58339087, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.58339087, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.58339087, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-LT-A5Z6-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.312, "MSI_SENSOR_SCORE": 0.23, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 15.36666667, "TISSUE_SOURCE_SITE": "Gundersen Lutheran Health System", "TBL_SCORE": 113.0 }, "treatments": [ { "START_DATE": 29, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 29, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-CF-A5U8": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "4CC25ADB-6DB4-46AA-9FC9-C2C6339FB6D3", "AGE": 59, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 399.0, "DAYS_TO_BIRTH": -21734.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/3/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 49.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.11766446, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.11766446, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.11766446, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.11766446, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-CF-A5U8-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "CF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3098, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-FD-A43X": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "4FF4D9FE-EAB8-4AB3-9AE4-9F15B2581A8F", "AGE": 84, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 110.0, "DAYS_TO_BIRTH": -30764.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/28/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 66.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 3.616398724, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 3.616398724, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 3.616398724, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 3.616398724, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FD-A43X-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FD", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3112, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.633333333, "TISSUE_SOURCE_SITE": "BLN - University Of Chicago", "TBL_SCORE": 26.0 }, "treatments": [] }, "TCGA-XF-A9T2": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "AA6B44AB-14B1-4B5D-8679-BA958B546AFA", "AGE": 54, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -19945.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/28/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 121.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 18.90390242, "DSS_STATUS": null, "DSS_MONTHS": 18.90390242, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.90390242, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9T2-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3136, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.633333333, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-UY-A9PA": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "45F5AF14-060A-49A3-B51D-25AB8A88FEB7", "AGE": 48, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 119.0, "DAYS_TO_BIRTH": -17520.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/1/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.2", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 75.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.24344939, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.24344939, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 35.24344939, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 35.24344939, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-UY-A9PA-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "UY", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3199, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.333333333, "TISSUE_SOURCE_SITE": "University of California San Francisco", "TBL_SCORE": 29.0 }, "treatments": [] }, "TCGA-GV-A3QK": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "9EE8E704-C61D-413D-B69D-257EF829FDAE", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 832.0, "DAYS_TO_BIRTH": -20802.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/27/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 83.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.3531249, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.3531249, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.3531249, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GV-A3QK-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "GV", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.329, "MSI_SENSOR_SCORE": 0.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.133333333, "TISSUE_SOURCE_SITE": "BLN - Cleveland Clinic", "TBL_SCORE": 52.0 }, "treatments": [ { "START_DATE": 126, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 126, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BT-A42E": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "8D434CFB-2414-4D93-BF79-7B957BF040DB", "AGE": 74, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1108.0, "DAYS_TO_BIRTH": -27045.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/10/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.4", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 83.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.42699806, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.42699806, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.42699806, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.42699806, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BT-A42E-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BT", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.324, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.3, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 93.0 }, "treatments": [ { "START_DATE": 49, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 49, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-XF-A8HC": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "17EE3278-DC2A-4021-A903-E4ED11E3218B", "AGE": 79, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -28996.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/13/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 62.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 6.575270408, "DSS_STATUS": null, "DSS_MONTHS": 6.575270408, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 6.575270408, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-XF-A8HC-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3205, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.9, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 100.0 }, "treatments": [] }, "TCGA-E7-A3Y1": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "F7C891EB-3B09-4E01-BB8A-53D570518CBE", "AGE": 57, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 163.0, "DAYS_TO_BIRTH": -20917.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 82.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 5.358845383, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 5.358845383, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 5.358845383, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 5.358845383, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E7-A3Y1-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "Low Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E7", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3125, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.066666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 29, "STOP_DATE": 53.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 36.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BL-A13I": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "ebc094a6-cdc9-4c02-b8ec-a181b25a364d", "AGE": 57, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -20885.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 51.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 7.331426505, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 7.331426505, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.101292041, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BL-A13I-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BL", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3343, "MSI_SENSOR_SCORE": 0.32, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.566666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 24.0 }, "treatments": [] }, "TCGA-YC-A89H": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "95520295-90D3-4B4E-86B6-4BD856723315", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 573.0, "DAYS_TO_BIRTH": -28741.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/21/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 44.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.83814972, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.83814972, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.83814972, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.83814972, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-YC-A89H-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "YC", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3228, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 45.73333333, "TISSUE_SOURCE_SITE": "Spectrum Health", "TBL_SCORE": 22.0 }, "treatments": [ { "START_DATE": 35, "STOP_DATE": 83.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 35, "STOP_DATE": 83.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-ZF-AA5H": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "04477379-6C51-45D9-B9B9-D05D53B53945", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 897.0, "DAYS_TO_BIRTH": -22122.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 82.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.49008778, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.49008778, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 5.819114311, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-ZF-AA5H-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "ZF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3208, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.866666667, "TISSUE_SOURCE_SITE": "University of Sheffield", "TBL_SCORE": 187.0 }, "treatments": [ { "START_DATE": 135, "STOP_DATE": 177.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 135, "STOP_DATE": 177.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FJ-A3ZE": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "917961E2-78AD-4182-9CDB-5EFB09808111", "AGE": 65, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 106.0, "DAYS_TO_BIRTH": -23866.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/27/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8120/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N3", "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 109.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 10.65193806, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 10.65193806, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 4.99720551, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FJ-A3ZE-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "FJ", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.356, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 12.5, "TISSUE_SOURCE_SITE": "BLN - Baylor", "TBL_SCORE": 107.0 }, "treatments": [ { "START_DATE": 62, "STOP_DATE": 99.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 28.0, "RADIATION_DOSAGE": 5600.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 275, "STOP_DATE": 299.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "radiographic progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 10.0, "RADIATION_DOSAGE": 3000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 56, "STOP_DATE": 99.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "radiographic progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 28.0, "RADIATION_DOSAGE": 5600.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-XF-A9T6": { "demographics": { "SUBTYPE": "BLCA", "CANCER_TYPE_ACRONYM": "BLCA", "OTHER_PATIENT_ID": "6EE18B9A-3F45-491F-9535-502820CFCF46", "AGE": 88, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 64.0, "DAYS_TO_BIRTH": -32207.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/5/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C67.9", "ICD_O_3_HISTOLOGY": "8130/3", "ICD_O_3_SITE": "C67.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3B", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 72.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.104086531, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.104086531, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.104086531, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XF-A9T6-01", "ONCOTREE_CODE": "BLCA", "CANCER_TYPE": "Bladder Cancer", "CANCER_TYPE_DETAILED": "Bladder Urothelial Carcinoma", "TUMOR_TYPE": "Muscle Invasive Urothelial Carcinoma (PT2 or Above)", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XF", "TUMOR_TISSUE_SITE": "Bladder", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3434, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.666666667, "TISSUE_SOURCE_SITE": "University of Southern California", "TBL_SCORE": 147.0 }, "treatments": [] } }